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The essential role of vitamin A in visual processes has been 
known for decades and is well understood (1). It is also important 
in some undefined manner, for epithelial differentiation, maintenance 
of reproductive capacity, and for the growth and general health of 
the normal animal (2-8). The parent substance, all-trans-retinol 
(vitamin A alcohol), can be chemically modified in many ways (9, 10) 
to give a large number of analogs collectively called retinoids (11). 
Some of these analogs showed less toxicity and better target organ 
specificity than retinal, while others were inactive (9, 11, 12). 
The term "vitamin A" is used to refer to those analogs which can 
restore normal growth in animals maintained on a vitamin A-deficient 
diet (7, 11). These include its naturally occurring oxitlation 
products, all-trans-retinal (vitamin A aldehyde) and all-trans-
retinoic acid (vitamin A acid), and a storage form, all-trans-retinyl 
palmitate. 
Retinoids and Neoplasia 
The possible relationship between vitamin A and cancer has 
attracted the attention of researchers since 1926, when Fujimaki (13) 
observed the development of stomach carcinomas in rats fed a vitamin 
A-deficient diet. It was also found that vitamin A deficiency leads 
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to metaplastic changes in the epithelial tissues of the gastrointes-
tinal, respiratory and urogenital tracts (2, 14-16). These changes 
may be considered to be among the first steps in the transformation 
from normal to neoplastic cells. Further support for the idea of a 
relationship between vitamin A and cancer came from studies which 
demonstrated that vitamin A deficiency enhanced the susceptibility 
of many epithelial tissues to carcinogenesis (17). In addition, 
several retinoids were shown to possess anti-tumor and/or anti-
carcinogenic activities both in vivo and in vitro (6, 9, 11, 17). 
In a study (18) using epidermal cells cultured on collagen, it 
was found that vitamin A favored cells' spreading, accelerated con-
fluence, and reduced the size of the multilayered cell colonies. 
The mode of shedding of cells into the medium was also altered. The 
effects of vitamin A on the markers of differentiation were hetero-
geneous as evidenced by its inhibition of keratinization in every 
case, and its induction of pre-keratinization, particularly at low 
concentrations. 
Felix et al. (19) showed that both the incidence and the growth 
of 891 melanoma in allogeneic mice was inhibited upon oral or intra-
peritoneal administration of retinyl palmitate two weeks before and 
after subcutaneous tumor inoculation. In another study, Rettura 
2 
et al. (20) used a syngeneic system in which the C3HBA mammary 
adenocarcinoma was inoculated subcutaneously in the nipple area of 
C3H/Hej female mice. They found that feeding retinyl palmitate 
(beginning on the day of tumor transplantation) slowed the tumor 
growth markedly. The treatment prolonged the survival of the animals, 
but did not decrease tumor incidence. Heilman and Swarm (21) found 
that 13-cis-retinoic acid prevented the development of tumor trans-
plants, and arrested tumor growth in rats bearing established tumors. 
Inhibition of tumor growth,and tumor regression by the trimethyl-
methoxyphenyl analogs of retinoic acid were also noted by Trown et al. 
(22). In other studies retinoic acid caused a regression of up to 
51.4% of chemically induced papillomas (23). Chemically induced skin 
carcinomas also regressed to some degree (24, 25). Studies by 
Edwards et al. (26) on the differentiation of a teratocarcinoma cell 
line suggested that the routes of differentiation in embryogenesis 
may be determined, in part, by concentration gradients of retinoids. 
At low concentrations .00-9M) of retinoic acid, the in vitro growth 
of S91 and B16 cells was inhibited by 55 and 30%, respectively (27). 
Lotan and Nicolson (28) studied the inhibitory effects of retinoic 
acid or retinyl acetate on the growth of untransformed, transformed, 
and tumor cells in vitro. The growth of all mammary tumor cell lines 
tested was inhibited. Human breast carcinoma H50578 was the least 
sensitive, whereas the growth of the rat mammary tumor cell line 
13762 NF was dramatically inhibited. 
Vitamin A was also shown to inhibit the growth and development 
of some virally induced benign and malignant tumors (29-31). Retinyl 
palmitate, in non-toxic amounts, inhibited the growth and enhanced 
the regression of both pox lesions and Murine-Sarcoma Virus-induced 
established tumors (30, 31). Atrophy and inhibition of growth of 
papillomas was achieved by administration of toxic doses of either 
.retinal or retinyl palmitate to rabbits inoculated with Shope rabbit 
papilloma virus (29). 
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Mode of Action of Vitamin A 
Several hypotheses have been proposed to explain the effects of 
vitamin A and/or its analogs on cells, and as anti-tumor and anti-car-
cinogenic agents: (1) The effects of retinoids on cell proliferation 
and differentiation are similar to the actions of several hormones. 
Steroid hormones are thought to affect gene expression by affecting 
the amounts of specific cytoplasmic mRNAs and/or ribosomal and 
transfer RNAs. They were also shown to induce alterations in nuclear 
enzymes, chromatin, and the synthesis of proteins (32). Several of 
these effects have been observed in cells or tissues treated with 
vitamin A. The similarities between the actions of retinoids and 
steroid hormones suggested comparable mechanisms of action. This 
suggestion was supported by the finding of specific intracellular 
retinoid binding proteins, reminiscent of steroid binding proteins, 
in many vitamin A affected tissues (33, 34). Thus, it was proposed 
that following entry of the retinoid into target cells, a complex is 
formed between it and its binding protein. The complex can then be 
translocated to the cell nucleus and can modulate gene expression 
(33, 34). 
(2) Another possible mechanism of action of retinoids is through 
an effect on glycolipid and glycoprotein synthesis. De Luca (6) 
suggested thatphosphorylated derivatives of retinoids may be involved 
in the glycosylation of membrane glycoproteins by acting as carriers 
of monosaccharides across the hydrophobic lipid bilayers. This may 
cause alterations in the glycosylation patterns of certain glycopro-
teins or glycolipids which may, in turn, affect the genome or alter 
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the cellular functions by epigenetic mechanisms (35-37). 
(3) Stimulation of humoral and/or cellular immunity was another 
postulated mechanism for the action of retinoids. Although retinal 
is in itself non-antigenic, it was shown to induce, in mice, the 
formation of antibodies to bovine gannna globulin by acting as an 
adjuvant (38). The same effect was seen in rats following adminis-
tration of retinal, retinal or retinoic acid (39), while retinyl 
acetate and retinyl palmitate were less effective. Retinyl palmitate 
induced a several fold stimulation of antibody production against 
other soluble proteins such as bovine serum albumin (40, 41). These 
studies demonstrated an enhancement of hurnoral responses to antigens 
by vitamin A. Parallel to these findings, it was also found that 
retinyl palmitate caused a significant reduction in rejection time 
if administered before or soon after grafting C57BL/6 mice with skin 
from isologous mice (42). Retinyl palmitate and retinoic acid also 
shortened the survival time of CBA/H mouse homograft in CBH mice by 
one half (43). These latter studies illustrated the activity of 
vitamin A as a stimulator of cell-mediated immune responses. 
13762 Rat Mannnary Adenocarcinoma 
In the present study, the 13762 rat mammary adenocarcinoma was 
used as a model to determine the effects of vitamin A and related 
retinoids on tumors because its glycoproteins, cell surface and some 
enzymes have been well characterized (44-55). Moreover, its growth 
is known to be inhibited by retinoids (28). 
The 13762 rat mammary adenocarcinoma is a dimethylbenzanthrene-
induced solid tumor (56). It was adapted for ascitic growth and 
5 
three morphologically distinct ascites sublines, MAT-A, MAT-B, and 
MAT-C were derived (57). After passage in vivo in the laboratory of 
K. L. Carraway (45), two additional sublines, MAT-Bl and MAT-Cl, 
6 
were obtained from MAT-Band MAT-C, respectively (Figure 1). MAT-A, 
MAT-B, and MAT-Bl cells could not be readily distinguished morpho-
logically. They had unbranched microvilli, ruffles, ridges and blebs 
associated with the cell surface. The MAT-Cl cells had a highly 
irregular surface and extensively branched microvilli with few ridges, 
ruffles and blebs (45). The MAT-C subline had an intermediate 
morphology. Most of the cells had numerous short, straight unbranched 
microvilli and few ruffles, ridges or blebs. About 10% of the popu-
lation had branched microvilli (45). Two of the five sublines (MAT-C 
and MAT-Cl) could be transplanted in ascitic form, into mice. The 
MAT-A, MAT-B, and MAT-Bl sublines were non-xenotransplantable (47). 
The MAT-Bl and MAT-Cl sublines have been extensively studied in 
the laboratory of Dr. K. L. Carraway. Both sublines have large 
amounts of a major high molecular weight cell surface sialoglyco-
protein (ASGP-1) identified by chemical, enzymatic and metabolic 
labeling (47, 49-51). The two sublines differed markedly in concana-
valin A receptor redistributions, and agglutinability by concanavalin A 
(45, 52). The two sublines also differed with respect to membrane 
sialoglycoprotein and sialic acid content, and the oligosaccharide 
composition and sulfation of ASGP-1 (~7-51). The physical properties 
of the MAT-Bl and MAT-Cl ASGP-1 were very similar. The amino acid 
compositions of both were essentially the same (46). 
In addition to the previously described 13762 rat mammary adeno-
carcinoma ascites sublines, new lines were obtained (Figure 1). New 
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sublines were derived from a variant (MR) of MAT-B adapted to cell 
culture by Dr. Erling Jensen, Mason Research Institute. Uncloned MR 
cells were injected into rats to give the MAT-MR2 ascites sublines. 
These latter cells were passaged until ASGP-1 appeared, after about 
19 passages, to give the MAT-MR2~s (51) subline. In addition, one 
of the clones of MR cells (50), named cMR6, was injected into rats 
to give an ascites tumor line (MAT~cMR6). This was passaged for 
about 18 passages before ASGP-1 appeared abruptly to give the MAT-
cMR6-S (50). The MR cells (cloned or uncloned) had fewer prominent 
microvilli than the ascites cells derived from them (54). However, 
the most dramatic morphological difference occurred at the stage of 
appearance of ASGP-1. The MAT-cMR6-S cells had branched microvilli, 
while the MAT-MR2-S did not (54). Both lines had limited receptor 
mobility upon treatment with fluorescent concanavalin A. The 
MAT-cMR6-S subline was xenotransplantable into mice whereas the 
MAT-MR2-S was not .. The oligosaccharide composition of ASGP-1 from 
the MAT-cMR6-S (54) was more similar to that of the MAT-Bl ASGP-1 
than to that of the MAT-Cl ASGP-1 (54). The MAT-MR2-S ASGP-1 
oligosaccharide pattern was simpler than any studied previously 
(54). 
Additional new sublines were obtained from the MAT-Cl subline. 
The MAT-Cl cells were passaged for more than four years during which 
one instance of spontaneous change was noted. The new variant was 
named MAT-C2. Concomitant with the change to the MAT-C2 form, a 
bacterial infection was discovered in the animal colony used for 
passage. About 25 passages of the MAT-C2 cells in healthy animals 
gave rise to what was named MAT-C3 cells (54). The MAT-C2 cells had 
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a predominant morphology similar to that of the MAT-MR2-S, not 
exhibiting the extensively branched microvilli of the MAT-Cl cells 
(47). The MAT-C2 oligosaccharide pattern also resembled that of 
the MAT-MR2-S with a slight shift, and the cells were not xenotrans-
plantable (54). The MAT-C3 cells were not xenotransplantable and 
few of them had branched microvilli. The oligosaccharide pattern, 
on Bio-Gel P-4, of their ASGP-1 reverted back to one resembling that 
of MAT-Cl cells (54). 
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_The present study was designed to evaluate the therapeutic 
potential of all-trans-retinoic acid against the 13762 rat mammary 
adenocarcinoma sublines. How retinoids alter the cells was the 
critical question. In an attempt to understand the mechanism of 
action, several parameters were measured: 1) tumor growth, xeno-
transplantability and survival of the tumor bearing animals; 2) cell 
morphology; 3) the density, molecular weight and oligosaccharide 
pattern of the major membrane glycoprotein (ASGP-1). The first two 
parameters are expressions of tumor behavior. The third is an 
expression of the effects of vitamin A on glycoprotein production. 
Any correlation between the effects of retinoids on tumor 
growth and the effects on these various cell parameters would be 
particularly significant. 
CHAPTER II 
THE EFFECT OF VITAMIN A ON THE MAJOR CELL 
SURFACE SIALOGLYCOPROTEIN OF THE 13762 
RAT MAMMARY ADENOCARCINOMA 
Introduction 
Glycoproteins play important roles in a number of cell surface 
phenomena (58, 59) including the escape of malignant tumor cells from 
immune surveillance by the host (60). One postulated mechanism is 
that the shedding of glycoproteins and cell surface antigens from the 
tumor may block the destruction of 'the tumor cells by the immune 
system (61-63). Another mechanism by which glycoproteins protect 
the tumor from immune surveillance is by masking the cell surface 
antigens (64). For example, two sublines of the mouse TA3 mammary 
adenocarcinoma have been studied and found to differ in morphology, 
agglutinability by concanavalin A, and transplantability across 
strain or species histocompatibility barriers (65)., The allo- and 
xenotransplantable TA3-Ha ascites cells had large amounts of 
epiglycanin, a major sialoglycoprotein. The strain specific TA3-St 
ascites cells had little or no epiglycanin (66, 67). It was postu-
lated that epiglycanin protects the tumor cells either by "masking" 
the histocompatibility antigen (64, 65) or by being released from 
the cell surface (68) to block immune destruction of the tumor (61, 
69). 
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The 13762 tumor sublines used in this study have large amounts o,f a 
major cell surface sialoglycoprotein (ASGP-1) which has been charac-
terized by chemical enzymatic and metabolic labeling (44, 46, 49-51, 
54). ASGP-1 contains> 70% of the [3H]glucosamine label incorporated 
into trichloroacetic acid-precipitable radioactivity in both MAT-Bl 
and MAT-Cl cells. The abundance (43, 44, 55) and organization (44) 
of ASGP-1 at the cell surface suggest that it plays a role in cell 
surface properties which are important to tumor survival. 
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The effects of retinoids on the biosynthesis of carbohydrate-
containing macromolecules are well documented. Studies revealed that 
the synthesis of specific glycoproteins in the epithelial cells of 
intestine, trachea and cornea decreased in vitamin A deficient animals 
(6, 70, 71). Administration of vitamin A to depleted animals stimu-
lated the synthesis. In a study using pre-chondrogenic mouse embryo 
limb bud, it was shown that retinoic acid inhibited the in vitro 
differentiation of mesenchymal cells to chondrocytes which form 
cartilaginous nodules (72). The control mesenchymal cells differen-
tiated and synthesized cartilage proteoglycan. Those cultures exposed 
to retinoic acid continued to produce proteoglycans characteristic ·of 
the prechondrogenic mesenchyme (72). In addition, the expression of 
two cell-surface proteins was also affected (73-75). Plotkin et al. 
(76) showed that vitamin A deficiency greatly·depressed galactosyl 
transferase activity in microsomes of rat tracheal epithelium. Galac-
tosyl transferase activity was restored by adding retinal to the 
microsomes or by dosing the deficient animals with retinyl acetate. 
De Pavia et al. (74) studied the effect of 1 to 5 doses of 15,000 
I.U. of vitamin A on N-acetyl neuraminic acid (NANA) concentrations in 
gingival tissues from rats. An increase in sialic acid concentration 
was observed in the animals that received up to 4 doses of vitamin A, 
while a decrease in concentration was observed in the group given 
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5 doses. De Luca et al. (78) demonstrated the presence of retinyl 
phosphate in mammalian liver, and that vitamin A deficiency decreased 
the pool of retinyl phosphate. Creek et al. (78) found that rat liver 
endoplasmic reticulum membranes catalyzed significant transfer of 
mannose to endogenous acceptor proteins in the presence of exogenous 
retinyl phosphate. This suggested the presence of GDP-mannose:retinyl 
phosphate mannosyl-transfer activity acting on glycoproteins at the 
postprocessing level. In another study, Comley et al. (80) demon-
strated the synthesis of retinyl phosphate mannose from GDP-mannose 
and exogenous retinyl palmitate in the~- pahani adult filarial nema-
tode microsomes, and suggested that retinyl phosphate may function 
as an intermediate carrier in filarial glycoprotein synthesis. Sasak 
et al. (81) showed an increase in the synthesis of higher molecular 
weight glycopeptides (MW 2100) and a corresponding decrease in the 
lower molecular weight fraction (MW 1500) of Balb/c 3Tl2-3 cell 
surface glycoprotein, upon retinoid treatment. Ferrari et al. (82) 
studied the effect of retinal on macromolecular synthesis in the 
SKMel 28 and HeLa cultured cell lines. Vitamin A caused a 60% 
inhibition of DNA synthesis when added at 50 µM concentration. This 
inhibition was reversible. In addition, the synthesis of cytoplasmic 
proteins, acid-soluble nuclear proteins and of non-histone chromosomal 
proteins was also inhibited by the vitamin. 
In studies on the use of retinoids in glycoprotein production, 
Chou (83) showed that retinoic acid induced the synthesis of low levels 
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of immunoreactive pregnancy-specific Sl-glycoprotein (PSSG). Syner-
gistic induction of PSSG synthesis was achieved when retinoic acid 
was used simultaneously with either 8-bromo-cAMP, cholera toxin, 
methyl isobutylxanthine, and 5-bromo-2'-deoxyuridine. Clark et al. 
3 
(84) showed that retinyl acetate increased the uptake of [ H]glucos-
amine and [ 14 ] . . d C serine into secrete mucins, in a concentration 
dependent manner. The studies also indicated that vitamin A has a 
greater effect on the synthesis of the carbohydrate moiety of the 
mucins, than on the protein moiety. 
Another type of retinoid-induced changes in surface glyco-
proteins has been reported. Borek et al. (85) observed that short 
exposure of rat liver cell cultures to retinal increased their 
agglutinability with plant lectins. In addition, retinal caused an 
increase in the proteolytic enzymes in the extracellular medium, 
and such enzymes are known to enhance cell agglutination. In another 
study (86) retinal treatment decreased the thickness of the surface 
Ruthenium red-staining material. The binding of positively charged 
colloidal iron particles was enhanced while negatively-charged 
colloidal particle binding was reduced, in 11210 Leukemia cells 
in vitro. These observations were similar to those on cell surfaces 
after neuraminidase treatment. It was thus suggested that retinal 
may cause the release of lysosomal neuraminidase. With human 
lymphocytes and mouse Landschutz ascites tumor cells, direct measure-
ment of released and cell-bound sialic acid showed that in retinal-
treated cells, sialic acid was released by cleavage of terminal 
residues, rather than by proteolytic cleavage of sialoglycopeptides 
(87). 
The previous examples and many others are demonstrations of 
the vitamin A-mediated modifications .of cellular glycoproteins, 
glycolipids, glycosaminoglycans, proteoglycans, and their biosyn-
thesis, in vivo and in vitro. Two types of changes in cell surface 
glycoconjugates have been described: An effect due to the release 
of lysosomal hydrolases (85-87), and a more specific effect, 
presumably a result of modulations in the glycosylation patterns 
of discrete glycoconjugates (6, 70-84). Retinoids could affect 
the rate of glycosylation, and possibly the type and amount of 
sugar moieties that comprise the carbohydrate portion of a glyco-
protein. As discussed previously, glycoproteins were implicated in 
several membrane and cell surface properties. The changes in the 
glycosylation of certain glycoproteins may affect the genome, and 
the cellular functions and.differentiation by epigenetic mechanisms 
(35). For example, the expression of some genomes may be altered 
at or beyond the tra~criptional level. In addition, changes in 
glycoprotein or other glycoconjugate production may alter membrane 
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or cell surface properties, thus altering, for example, intercellular 
recognition, adhesion and aggregation processes which are involved· 
in differentiation (36, 37). The alterations in the membrane glyco-
proteins themselves, or in other cellular functions and cell surface 
properties could affect the survival of tumor cells. Therefore, 
the objective of this research was to determine the effects of 
vitamin A on the 13762 rat mammary adenocarcinoma cells and their 
major cell surface glycoprotein (ASGP-1). This glycoprotein has 
been implicated in roles essential for.the tumor survival. The 
results of our studies on ASGP-1 are presented in some detail later in 
16 
this chapter. 
Materials and Methods 
Materials 
14 · 3 
D-[1~ C]Glucosamine (50 to 60 mCi/mmol), D-[1- H]glucosamine 
(2 to 6 Ci/mmol) and D[-1-3H]galactose (9-11 Ci/mmol) were obtained 
from Amersham; Instagel was from Packard; guanidine hydrochloride 
(grade 1) was from Sigma; CsCl (99.99%) was purchased from Varlacoid. 
All-trans-retinoic acid was a gift from Hoffmann-La Roche, Inc., and 
was in the form of gelatinized beadlets containing 10.3% retinoic 
acid by weight. 
Vitamin A deficient purified diet (Table I) was prepared for us 
by and purchased from Teklad (Madison, WI). Wayne certified Lab-Blox, 
a non-purified closed formula diet was purchased from Wayne Feed 
Division, Continental Grain Company (Chicago, IL). 
F-344 female rats, 28 days old, were obtained from Charles River 
Breeding Laboratories (Wilmington, MA). 
Tumor Sublines and Cells. Initially, a preliminary study was 
attempted on the effects of "vitamin A" on the MAT-Cl and the MAT-Bl 
cells, since these sublines have been thoroughly studied, more than 
any others, in the laboratory of Dr. K. Carraway. However, the 
maintenance of the MAT-Cl tumor line could not be achieved in our 
laboratory, as initially evidenced by electron microscopic studies 
on cell morphologies. Studies on the ASGP-1 oligosaccharide pattern 
indicated that they have a pattern resembling that shown for MAT-Cl 
and MAT-C3 cells (46, 54). The morphology mainly resembled that of 
TABLE I 
VITAMIN A DEFICIENT PURIFIED DIET FOR RATS 
Ingredient 





Mineral Mix, AIN-76 1 
Biotin 
Vitamin B12 (0.1% Trituration in Mannitol 
Calcium Pantothenate 
Choline Dihydrogen Citrate 
Folic Acid 





DL-Alpha Tocopheryl Acetate (100 U/g) 
Vitamin D in Corn Oil (400,000 U/g) 





















the MAT-C cells, with short stubby unbranched microvilli. It was 
decided that the cells were of the MAT-C3 line. Both before and 
while the preliminary studies were carried out, the two laboratories 
exchanged tumor bearing rats. It was during that time that the 
changes from MAT-Cl-to MAT-C2 to MAT-C3 were observed in the labora-
tory of Dr. K. Carraway (54), In the preliminary studies, the 
morphology and oligosaccharide pattern of the MAT-Bl cell line were 
as reported previously (47). 
In another attempt to study the effects of "vitamin A" on the 
MAT-Bl and MAT-Cl sublines, tumor bearing rats were obtained from 
Dr. K. Carraway. Again, the attempts to maintain these close to 
homogeneous lines in our laboratory failed. Based on the morpho-
logical and biochemical studies it was decided that we had a 
heterogeneous MAT-B population termed "MAT-BH" and a heterogeneous 
MAT-C population termed "MAT-CH". In · the present study, the MAT-Bl, 
MAT-C3, MAT-BH and MAT-CH lines were used. These sublines were 
maintained by routine weekly passage as described previously (47). 
After recovery from the peritoneal cavity, the cells were washed 
three times with cold Dulbecco's phosphate buffered saline without 
calcium or magnesium, by centrifugation at 100 x gin an SS-34 rotor 
for 3 min. 
Methods 
Cell Labeling. Metabolic labeling with [3H]glucosamine (70-100 
µCi) or [14c]glu~osamine (30 µCi) was accomplished by injection of 
the compound in 0.2 ml of 0.9% NaCl into the peritoneal cavity of 
a tumor-bearing rat, approximately 16 h prior to killing the animals 
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and recovery of the cells. 
Measurement of Radioactivity. Aliquots of gradient or column 
fractions were mixed with 4~5 ml of scintillation fluid and counted 
in a model PL-1 Frias liquid scintillation counter (Packard). The 
3 14 
H- and C-counts were corrected for efficiency and overlap using the 
e~ternal standard channels. ratio when both isotopes were used. 
Membrane Preparation. Membrane vesicles were obtained as 
described by Sherblom et al. (46) and Huggins et al. (44): The washed 
cells were suspended in 10 volumes of 10 mM Tris, pH 8.0 and after 2 
minutes on ice were centrifuged at 600 x gin a Sorvall SS-34 rotor 
for 2 min. The swollen cell pellet was suspended in 10 volumes of 10 
mM Tris, pH 8.0 and homogenized by 5 to 6 strokes of a Dounce homogen-
izer with a tight pestle. Breaking of the cells was monitored by 
phase contrast microscopy and was stopped when 70-80% of the cells 
were broken and the nuclei appeared distended. To stabilize the 
nuclei, 0.1 volume of 100 mM NaCl, 30 mM MgCl was added. Centrifuga-
tion of the homogenate at 1000 x g for 1 min pelleted the nuclei 
which were discarded. The resulting supernatant solution was 
centrifuged at 10,000 x g for 10 min (SS-34 rotor). The supernatant 
solution from this step was then, in turn, centrifuged at 100,000 x 
g for 105 min (Beckman SW 27 or SW 28 rotor). · The resulting pellet 
(crude membrane fraction) was suspended in 4 M guanidine HCl using a 
small Dounce homogenizer. 
Purification and Density Determination of ASGP-1. Aliquots of 
crude membrane fractions from the cells were mixed with those from 
20 
their corresponding controls in different cell combinations. In some 
cases, groups of cells from one or more supplemented rats were mixed 
with cells from each of two different control rats, separately. In 
other cases, the cells from one control rat were mixed with each of 
two different cell groups from separate supplemented rats. The type 
of combination used depended on the availability of sample. Each 
mixture was layered onto preformed CsCl gradients (46) (density, 1.3 
to 1.5 g/ml, in 4 M guanidine HCl) which were centrifuged in a Beckman 
0 
Ti 75 rotor at 4 C, 270,000 x g for 22-24 h. Fractions were collected 
from the bottom of the gradients. Densities of selected fractions 
from the CsCl gradients were determined by the difference in dry and 
filled weight of a 50 µ1 pipet calibrated with distilled water. 
Fractions representing the major radioactive peak were pooled as 
ASGP-1. CsCl andGdnHCl were removed from these fractions by dialy-
sis/concentration into distilled water using a collodion bag 
apparatus (Schleicher and Schuell). The dialysate concentrate 
contained ASGP-1 and was dissolved in approximately 1.0 ml of dis-
tilled water. 
Gel Filtration with 1% SDS. An aliquot of experimental and 
control ASGP-1 mixture, which had been dialyzed against distilled 
water, was solubilized with 1% SDS, 50 mM Tris, pH 8.0 and applied 
to a Sepharose CL-2B column (1 x 110 cm) equilibrated and eluted 
with the same buffer. A fraction collector was used to collect 
the 80 drop fractions. Aliquots (100 µ1) were analyzed for radio-
activity. 
Alkaline Borohydride Treatment. An aliquot of the ASGP-1 samples 
that had been purified on CsCl gradients, dialyzed and concentrated, 
was incubated at 45°c with 1.0 M NaBH~ 0.05 M NaOH for 16 hand then 
neutralized with glacial acetic acid. The treated sample was then 
applied to a Bio-Gel P-4 (200-400 mesh) column (1 x 110 cm) equili-
brated and eluted with 0.1 M pyridine acetate, pH 6.0. The 25 drop 
fractions were collected using a fraction collector. Aliquots (100 
µ1) of the eluting fractions were analyzed for radioactivity. The 
column was calibrated with dextran and galactose. 
Statistical Analysis. The Wald-Wolfowitz two-sample runs test 
was used to detect significant peak shifts at the 0.05 signifi-
cance level (P < • 05). Data were normalized on a percentage basis 
before the test was applied. 
Experimental Design 
MAT-Bl and MAT-C3 Sublines. Upon arrival, the female rats were 
processed through routine quarantine procedures for 10 days. They 
were fed the non-purified diet until the animals were required for 
experimentation. Each experimental period started by dividing the 
rats, which belonged to the same age group, into a supplemented and 
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a control group. In the case of the MAT-Bl subline,, four experiments 
(I, II, III and IV) were performed over four different time periods. 
In each experiment, there was a supplemented group and a respective 
control group, each group consisting of 3 to 5 rats. In experiment I, 
the rats of the supplemented group (group I) were fed the vitamin 
A-deficient purified diet supplemented with 12 mg of retinoic acid/kg 
diet. In experiments II, III and IV, the corresponding supplemented 
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groups II, III and IV received 60, 90 and 120 mg retinoic acid/kg diet, 
respectively. As mentioned earlier, each experiment had its own con-
trol group, and all the control groups were continued on the closed 
formula non-purified diet. The same was the case for the MAT-C3 
subline. However, only three experiments were performed. In experi-
ment I, group I was fed the vitamin A-deficient purified diet 
supplemented with 12 mg retinoic acid/kg diet. For experiments II 
and III, groups II and III were fed 60 and 120 mg retinoic acid/kg 
diet. The controls from all the experiments were fed the non-purified 
diet (Table II). 
The control and the retinoic acid supplemented animals were kept 
on their respective diets for three weeks. However, at the beginning 
of the third week, the animals (60-90 days old) received intraperi-
toneal injections of either MAT-Bl (2.8-3 x 106) or MAT-C3 (1.2-1.4 
x 106) tumor cells. At the end of the third week, the animals were 
killed and the tumor cells were recovered from the peritoneal cavity. 
MAT-BH and MAT-CH Sublines. For each of the sublines used in 
this experiment, the animals, which belonged to the same age group, 
were divided into a control group and three different supplemented 
groups, I, II, and III. Each group consisted of 4 to 6 rats. Group 
I received approximately 4.5 mg retinyl palmitate/kg purified, 
vitamin A deficient diet. Groups II and III were fed the vitamin 
A-deficient purified diet supplemented with 60 and 120 mg retinoic 
acid/kg diet, respectively (Table III). Other experimental conditions 
were the same as for the MAT-Bl and MAT-C3 sublines. The 4.5 mg 
retinyl palmitate/kg purified diet is considered an adequate dietary 
vitamin A supplement. Also, the supplemented rats were not vitamin 
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TABLE II 
THE MAT-Bl AND MAT-C3 DIET GROUPS 
Sub line Group Diet and Supplement 
MAT-Bl Controls (C) Non-purified Diet 1 
I 12 mg RA1kg Purified Diet 
II 60 mg RA/kg Purified Diet 
III 90 mg RA/kg Purified Diet 
IV 120 mg RA/kg Purified Diet 
MAT-C3 Controls (C) Non-purified Diet 
I 12 mg RA/kg Purified Diet 
II 60 mg RA/kg Purified Diet 
III 120 mg RA/kg Purified Diet 
1 
2 mg carotene, 4.5 mg retinyl palmitate/kg diet. 
2All-trans-retinoic acid. 
TABLE III 
THE MAT-BR AND MAT-CH DIET GROUPS 
Tumor Line Group Diet and Supplement 
MAT-BH Controls (C) Non-purified Diet1 
') 
I 4.5 mg RP~/kg Purified Diet 
II 60 mg RA3/kg Purified Diet 
III 120 mg RA/kg Purified Diet 
MAT-Cll Controls (C) 
I 4.5 mg RP/kg Purified Diet 
II 60 mg RA/kg Purified Diet 
III 120 mg RA/kg Purified Diet 
1 
2 mg carotene, 4.5 mg retinyl palmitate/kg diet. 
2All-trans-retinyl palmitate (Rovimix A-325, Hoffmann-La 
Roche-Nutley, New Jersey). 
3All-trans-retinoic acid. 
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A deficient. They had a normal retinal status, but were supplemented 
with pharmacological doses of all-trans-retinoic acid, or with 
adequate doses of retinyl palmitate. The 60 mg retinoic acid/kg 
diet is equivalent to 23 x vitamin A levels in vitamin A sufficient 
diets. The 120 mg retinoic acid/kg diet is equivalent to 46 x vitamin 
A levels in vitamin A sufficient diets. 
Results 
Density Gradient Centrifugation 
Control ASGP-1 was copurified with ASGP-1 from each of the 
experimental groups, using preformed CsCl gradients in 4 M Gdn HCl 
as explained in the methods. Inspection of the density gradient 
profiles for MAT-Bl membrane vesicles revealed no apparent density 
differences between glycoprotein from group I, III (Figure 2), or 
IV and that from control. ASGP-1 from group II seemed less dense 
or slightly less dense than control ASGP-1. The density profiles 
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for the MAT-C3 revealed no density differences between group II 
(Figure 3) or group III glycoprotein and control MAT-CJ ASGP-1. 
However, group I ASGP-1 appeared to be less dense than control ASGP-1 
(Figure 4). 
Density gradient profiles for membrane vesicles from MAT-BR and 
MAT-CH cells indicated that MAT-BR ASGP-1 from group I cells had a 
higher density than control MAT-BR ASGP-1 (Figure 5). ASGP-1 from 
group II MAT-BR cells was as dense or slightly less dense than 
control ASGP-1. ASGP-1 from group III cells was as dense as control 
MAT-BR ASGP-1 (Figure 6). 
In the case of the MAT-CH line, the results varied from one 
Figure 2. Density Gradient Centrifugation of MAT-Bl Membrane Vesicles 
from Control and Group III in CsCl Gradients Containing 
4 M Gdn HCl. Membrane vesicles from [3H]glucosamine-
labeled group III (90 mg retinoic acid/kg diet) MAT-Bl 
cells (.6.) mixed with membrane vesicles from [14c]-
glucosamine-labeled control MAT-Bl cells ( •). Density 
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Figure 3. Density Gradient Centrifugation of MAT-C3 Membrane Vesicles 
from Control and Group II in CsCl Gradients Containing 
4 M Gdn HCl. Membrane vesicles from [3H]glucosamine-
labeled group II (60 mg retinoic acid/kg diet) M.AT-C3 
cells (.6.) mixed with [14c]glucosamine-labeled control 
MAT-C3 cells ( • ) • Density curve ( *). 
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Figure 4. Density Gradient Centrifugation of MAT-C3 Membrane Vesicles 
from Control and Group I in CsCl Gradients Containing 
4 M Gdn HCl. Membrane vesicles from [3H]glucosamine-
labeled group I (12 mg retinoic acid/kg diet) MAT-C3 
cells (.6.) mixed with membrane vesicles from [14c]-
glucosamine-labeled control MAT-C3 cells ( •). Density 
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Figure 5. Density Gradient Centrifugation of MAT-BR Membrane Vesicles 
from Control and Group I in CsCl Gradients Containing 
4 M Gdn RCl. Membrane vesicles from [14c]glucosamine-
labeled group I (4.5 mg retinyl palmitate/kg diet) 
MAT-BR cells (•)mixed with membrane vesicles from 
[3R]glucosamine-labeled control MAT-BR cells (~). 
Density curve ( *). ' 
33 
25 1.5 
1.4 ....... -....... E ?fl 
......... ......... 
C') 
:E 15 1.3 ........ a. > c .... -




0 5 10 15 
ELUTION WEIGHT (g) 
Figure 6. Density Gradient Centrifugation of MAT-BR Membrane Vesicles 
from Control and Group III in CsCl Gradients Containing 
4 M Gdn RCl. Membrane vesicles from [ 3R] glucosamine-
labeled group III (120 mg retinoic acid/kg diet) MAT-BR 
cells (.6.) mixed with membrane vesicles from [14c]-
glucosamine-labeled control MAT-BR cells (• ). Density 
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group to another. Upon comparing group I ASGP-1 with control, group 
I ASGP-1 appeared more dense than control MAT-CH ASGP-1 in one cell 
combination (Figure 7), and less dense in another. Group II ASGP-1 
appeared either as dense or slightly less dense than control ASGP-1 
(Figure 8). ASGP-1 from group III was less dense than control in the 
two combinations tested (Figure 9). 
Characterization of ASGP-1 by Gel Chromatography 
on Sepharose CL-2B 
36 
As described in the Materials and Methods, glycoproteins from 
different combinations of ASGP-1 from supplemented groups and their 
respective controls were copurified. Aliquots from each of the puri-
fied combinations were applied to 'a Sepharose CL-2B column. Gel 
chromatography profiles for the MAT-Bl subline revealed no significant 
differences between group I or group II or group IV (Figure 10) 
glycoproteins and control. However, group III glycoprotein was 
significantly higher. (P < .05) in molecular weight than control MAT-
Bl glycoprotein. MAT-C3 glycoproteins from all the supplemented 
groups were significantly (P< .05) lower in molecular weight than 
control MAT-C3 ASGP-1 (Figure 11 and 12). 
Gel filtration data for the MAT-BR subline indicated that group 
I ASGP-1 was either larger (P< .05), in one cell combination (Figure 
13), or as large as control MAT-BH ASGP-1 in another. Group II ASGP-1 
was smaller than control MAT-BH ASGP-1 (P< .05) in both combinations 
tested, and might be less heterogeneous. ASGP-1 from group III MAT-BH 
cells was consistently smaller (P < .05) than control ASGP-1 (Figure 14). 
MAT-CH glycoprotein from group I was larger (P < • 05) than control in both 
combinations studied (Figure 15). ASGP-1 from groups II and III were 
Figure 7. Density Gradient Centrifugation of MAT-CH Membrane Vesicles 
from Control and Group I in CsCl Gradients Containing 
4 M Gdn HCl. Membrane vesicles from [3H]glucosamine-
labeled group I (4.5 mg retinyl palmitate/kg dift) MAT-CH 
cells(~) mixed with membrane vesicles from [ 1 C]-
glucosamine-labeled control MAT-CH cells (• ). Density 
curve ( *). 
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Figure 8. Density Gradient CentI;'i~ugation of MAT-CH Membrane Vesicles 
from Control and Group II in CsCl Gradients Contain~ng 
4 M Gdn HCl. Membrane.vesicle$ from [3H]glucosamine-
labeled· group II (60 mg retinoic acid/kg diet) MAT-CH (6) 
cells were mixed with membrane vesicles from [14c]- .. 
glucosamine-labeled control MAT-CH cells(•). Density 
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:Figure 9. Density Gradient Centrifugation of MAT-CH Membrane Vesicles 
from Control and Group III in CsCl Gradients Containing 
4 M Gdn HCl. Membrane vesicles from [3H]glucosamine-
labeled group III (120 mg retinoic acid/kg diet) MAT-CH 
cells (.6.) mixed with membrane vesicles from [14c]-
glucosamine-labeled control MAT-CH cells ( •). Density 
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Figure 10. Gel Filtration of Purified MAT-Bl ASGP-1 from Control and 
Group IV on Sepharose CL-2B with 1% SDS. [3H]glucos-
amine-labeled MAT-Bl ASGP-1 from group IV (120 mg 
retinoic acid/kg diet) (.6.) mixed with [14c]glucosamine-
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Figure 11. Gel Filtration of Purified MAT-C3 ASGP-1 from Control and 
Group I on Sepharose CL-2B with 1% SDS. [3H]glucosamine-
labeled MAT-C3 ASGP-1 from group I (12 mg retinoic acid/ 
kg diet) (~) mixed with [14c]glucosamine-labeled control 





















Figure 12. Gel Filtration of Purified MAT-C3 ASGP-1 from Control and 
Group III on Sepharose CL-2B with 1% SDS. [3H]-
glucosamine-labeled MAT-C3 ASGP-1 from group III (120 mg 
retinoic acid/kg diet) (~) mixed with [14c]glucosamine-
labeled control MAT-C3 ASGP-1 (e), 
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Figure 13. Gel Filtration of Purified MAT-BR ASGP-1 from Control and 
Group I on Sepharose CL-2B with 1% SDS. [1 4c]glucos-
amine-labeled MAT-BR ASGP-1 from group I (4.5 mg retinyl 
palmitate/kg diet) ( •) mixed with [3R] glucosamine-labeled 
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Figure 14. Gel Filtration of Purified MAT-BR ASGP-1 from Control and 
Group III on Sepharose CL-2B with 1% SDS. [3R]glucos-
amine-labeled MAT-BR ASGP-1 from group III (120 mg 
retinoic acid/kg diet) (./::,..) mixed with [14c]glucosamine-
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Figure 15. Gel Filtration of Purified MAT-CH ASGP-1 from Control and 
Group I on Sepharose CL-2B with 1% SDS. [3H]glucos-
amine-labeled MAT-CH ASGP-1 from grouf I (4.5 mg retinyl 
palmitate/kg diet) (.6.) mixed with [l C]glucosamine-









6 6 ,- >< 
>< I I :E I 
:E I c. 
c. I c 
c 4 l 4 0 I 
:c I v I ~ (i) I 
7 
l::,. T I 
I l::,. ......... 







'f::,:~1::,,.6:b; 6. ·f:::d:::..b,:6.· 
10 20 30 40 
FRACTtO·N 
SS 
consistently significantly larger (P< .05) than control MAT-CH 
ASGP-1 (Figure 16). 
Oligosaccharides Released by Alkaline 
Borohydride Treatment 
Release of the 0-linked oligosaccharides of ASGP-1 was accom-
plished by alkaline borohydride B-elimination (88). Bio-Gel P-4 
chromatography of the alkaline borohydride digest from MAT-Bl cells 
resulted in the separation of three major glucosamine containing 
oligosaccharides. The labeling studies revealed that the majority 
of the MAT-Bl oligosaccharides were found in peaks III and IV as 
shown previously for the MAT-Bl subline by Sherblom et al. (46). 
No significant differences in the oligosaccharide patterns of control 
and each of group II, III, or IV (Figure 17 and 18) MAT~Bl ASGP-1 
were observed. In the case of group I, there was not enough sample 
to run the oligosaccharide test. Labeling studies revealed no 
differences in the oligosaccharides released by alkaline borohydride 
treatment of copurified group I and control MAT-C3 ASGP-1 (Figure 
19). For both glycoproteins, the oligosaccharides appeared predomi-
nantly in peaks II and III upon gel filtration on a Bio-Gel P-4 
column as shown previously for MAT-C3 ASGP-1 (54). On the other 
hand there were distinct differences (P < . 05) "in the released oligo-
saccharides when MAT-C3 ASGP-1 from group III and control cells were 
compared (Figure 20). The 14c and 3H peaks were not coincident at 
peak II. This suggested that the control and group III oligo-
saccharides that comprise this peak might not be the same. 
14 
The C 
3 and H peaks coincide at peak III. The shoulder to the side of the 
Figure 16. Gel Filtration of Purified MAT-CH ASGP-1 from Control and 
Group III on Sepharose CL-2B with 1% SDS. [3H]glucos-
amine-labeled MAT-CH ASGP-1 from group III (120 mg 
retinoic acid/kg diet) (.6.) mixed with [14c]glucosamine-
labeled control MAT-CH ASGP-1 ( • ) . 
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Figure 17. Gel Filtration of Oligosaccharides from Control and Group 
II MAT-Bl ASGP-1 on Bio-Gel P-4. [3H]glucosamine-
labeled oligosaccharides of MAT-Bl ASGP-1 from Yroup II 
(60 mg retinoic acid/kg diet) (-¢-) mixed with [ 4c]-
glucosamine-labeled oligosaccharides of control MAT-Bl 
ASGP-1 ( •). 
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Figure 18. Gel Filtration of Oligosaccharides from Control and Group 
IV MAT-Bl ASGP-1 on Bio-Gel P-4. [3H]glucosamine-
labeled oligosaccharides of MAT-Bl ASGP-1 from group IV 
(120 mg retinoic acid/kg diet) (-¢-) mixed with [14c]-
glucosamine-labeled oligosaccharides of control MAT-Bl 
ASGP-1 ( e). 
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figure 19, Gel Filtration of Oligosaccharides from Control and Group I 
MAT-C3 ASGP-1 on Bio-Gel P-4. [3H]glucosamine-labeled 
oligosaccharides of MAT-C3 ASGP-1 from group I (12 mg 
retinoic acid/kg diet) (-¢-) mixed with [ 14c]glucosamine-
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Figure 20. Gel Filtration of Oligosaccharides from Control and Group 
. III MAT-C3 ASGP-1 on Bio-Gel P-4. [3H]glucosamine-
labeled oligosaccharides of MAT-C3 ASGP-1 from group III 
(120 mg retinoic acid/kg diet) (.i:t-) mixed with [14c]-
glucosamine-labeled oligosaccharides of control MAT-C3 


































3H peak suggested a greater heterogeneity of oligosaccharide with a 
shift towards the lower molecular weight oligosaccharides. With 
respect to MAT-C3 group II, there was not enough sample to obtain 
the oligosaccharide pattern. 
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The results of oligosaccharide studies on the MAT-BH and MAT-CH 
sublines were variable. When MAT-BH ASGP-1 from group I was compared 
with control MAT-BH ASGP-1, their oligosaccharide patterns coincided 
(Figure 21). However, in one of the cell combinations, there 
appeared to be a slight increase in the relative amount of peak II 
oligosaccharides of group I c14c labeled). When MAT-BH ASGP-1 from 
groups II and III (Figure 22) was compared to.the control, the 3H 
and 14c peaks were not coincident, mainly at peaks III and IV. 
The oligosaccharides comprising the 3H peaks (group III) appeared 
to be larger in the average molecular weight than those of the 14c 
peaks (control). In addition, there seemed to be a slight decrease 
in the relative amount of peak II as compared to control, in all 
combinations studied. However, a large apparent increase in the 
relative amount of peak IV from group III was observed in one of the 
cases where group III and control glycoproteins were compared (Figure 
22). 
The MAT-CH oligosaccharide pattern (Figures 23 and 24) was 
different from that of the MAT-BH (Figures 21 ·and 22). The MAT-CH 
oligosaccharides was predominantly found in peaks II and III as 
shown for the MAT-Cl subline by Sherblom et al. (46). When control 
MAT-CH ASGP-1 was compared to ASGP-1 from the other groups, the main 
differences appeared to be between control and group I ASGP-1 
(Figure 23). In this case, the 3H and 14c peaks did not coincide 
Figure 21. Gel Filtration of Oligosaccharides1!rom Control and Group I 
MAT-BH ASGP-1 on Bio-Gel P-4. [ C]glucosamine-labeled 
oligosaccharides of MAT-BH ASGP-1 from group I (4.5 mg 
retinyl palmitate/kg diet) (•) mixed with [3H]glucos-
amine-labeled oligosaccharides of control MAT-BH ASGP-1 
( ~). 
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Figure 22. Gel Filtration of Oligosaccharides from Control and Group 
III MAT-BR ASGP-1 on Bio-Gel P-4. [3R]glucosamine-
labeled oligosaccharides of MAT-BR ASGP-1 from group III 
(120 mg retinoic acid/kg diet) ( -p-) mixed with [ 14c]-
glucosamine-labeled oligosaccharides of control MAT-BR 
ASGP-1 ( e). 
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Figure 23. Gel Filtration of Oligosaccharides from Control and Group I 
MAT-CH ASGP-1 on Bio-Gel P-4. [3H]glucosamine-labeled 
oligosaccharides of MAT-CH ASGP-1 from group I (4.5 mg 
retinyl palmitate/kg diet) . ( ¢-) mixed with [ 14c] glucos-
amine-labeled oligosaccharides of control MAT-CH ASGP-1 
(.). 
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Figure 24. Gel Filtration of Oligosaccharides from Control and Group 
III MAT-CH ASGP-1 on Bio-Gel P-4. [3H]glucosamine-
labeled oligosaccharides of MAT-CH ASGP-1 from group III 
(120 mg retinoic acid/kg diet) ( ,¢-) mixed with 
[14c]glucosamine-labeled oligosaccharides of control 
MAT-CH ASGP-1 ( e ) . 
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at peak II. The peak II oligosaccharides of group I appeared to be 
less heterogeneous than that for control. The whole oligosaccharide 
pattern was significantly (P < • 05) shifted to the right from control 
in one of the cell combinations of I vs. control. The oligosaccharide 
patterns of groups II and III seemed to match that of the control 
(Figure 24) except for, in some instances, a very slight decrease in 
the relative amount or an increase in heterogeneity of the oligo-
saccharides of peak III. 
Discussion 
In this chapter, the effects of dietary retinyl palmitate and 
retinoic acid on the density, molecular weight and oligosaccharide 
patterns of the 13762 rat mammary adenocarcinoma cell membrane major 
glycoprotein ASGP-1 were investigated. The effects varied with the 
ascites tumor sublines used and/or with the type and concentration 
of retinoid used. The observations on the density of the glyco-
protein varied from no effects (MAT-Bl groups I, III and IV; MAT-C3 
groups II and III; MAT-BR groups II and III) to an increase [MAT-BR 
group I; MAT-CH group I (one cell combination)], or a decrease [MAT~Bl 
group II; MAT-C3 group I; MAT-CH groups I (one cell combination), II 
or III] in the density of the glycoprotein from supplemented rats as 
compared to control. The densities of. glycoproteins depend largely 
on the carbohydrate/protein ratio and also on the type of carbohydrate 
residues present. An increase in density suggests a higher carbo-
hydrate/protein ratio and/or a higher percentage of acidic residues, 
such as sialic acid, which bind Cs+, and tend to have lower partial 
specific volumes. On the other hand, a decrease in density suggests 
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a lower carbohydrate/protein ratio and/or a decrease in the percentage 
of acidic residues. 
The glycoproteins' molecular weights also varied. The molecular 
weights of ASGP-1 from MAT-Bl groups I, II or IV were not affected by 
dietary retinoic acid. The molecular weights of the glycoproteins 
from MAT-C3 groups I, II or III, and MAT-BR groups II and III were lower 
than those of controls. ASGP-1 from MAT-Bl group III, MAT-BH group 
I (one replica), or from MAT-CH groups I, II or III was larger than 
ASGP-1 from _the respective controls. A change in the number and/or 
type of carbohydrate and/or amino acid residues would affect the 
molecular weight of a glycoprotein. 
The oligosaccharide patterns of the MAT-Bl and the MAT-BR sub-
lines were as shown previously for the MAT-Bl subline (46). The 
majority of oligosaccharides were in peaks III and IV. In the case 
of the MAT-C3 and MAT-CH sublines, the oligosaccharide patterns 
resembled those previously shown for the MAT-C3 subline (54). 
Previous studies (54, 89) showed that MAT-Bl peak II was homogeneous 
and disialylated with the following structure: 
II-3: 








MAT-Bl peak III was found to be heterogeneous with respect to 
its oligosaccharide composition. It was deduced to be a mixture of 






























MAT-Bl peak IV was also found to be heterogeneous and neutral. 
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It consisted of 2 fucosylated and two non-fucosylated oligosaccharitol 
chains with the following proposed structures (89): 
IV-la: 
IV-lb: 


































The MAT-C3 and MAT-CH oligosaccharide patterns resembled those 
shown for MAT-C3 (54, 89). The MAT-C3 pattern itself resembled that 
of MAT-Cl shown by Sherblom et al. (46). The oligosaccharide compo-
sitions of MAT-Bl and MAT-Cl ASGP-1 were found·to be only quanti-
tatively different, as shown in Table IV [taken from Hull, S. R., 
1982 (89)]. 
3 14 The observations that the Hand C peaks of oligosaccharide 
patterns did not coincide, in some cases, suggested that they differ 
in oligosaccharide composition. The difference in oligosaccharide 
composition, in turn, can be due to changes in the number of carbo-
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hydrate residues of the oligosaccharides present in a peak, or in the 
relative amounts of the different oligosaccharides comprising a 
Bio-Gel P-4 peak. For example, in the case of the MAT-BH subline, 
3 14 group III (Figure 22), the Hand C, did not coincide. Group III 
3 ASGP-1 ( H) had peaks III and IV shifted to the left as compared to 
those from control ASGP-1. This suggested that group III peaks had 
a higher relative amount of the larger oligosaccharides comprising 
the peak. The number of carbohydrate residues/oligosaccharide does 
not seem to be the only determinant of the chromatographic profile 
TABLE IV 
RECOVERY OF GLUCOSAMINE LABEL IN THE OLIGOSACCHARITOL 
FRACTIONS OF MAT-Bl AND MAT-Cl ASGP-1 1 
% Glucosamine Recovered0 
Fraction 
MAT-Bl MAT-Cl 
I 8.7 16.3 
II 15.6 39.3 
III 40.5 34.5 
IV 35.0 9.8 
1 
Taken from Hull, S. R. 1982 (89). 
0 Radioactive counts were quantitated for each 




and position on Bio-Gel P-4. For example, as shown by Hull (89), 
MAT-Bl peak II, peak III-2b and III-2c all have 6 sugar residues. 
However, they chromatograph differently on Bio-Gel P-4. Thus, 
differences in the types of sugar residues present in the oligosaccha-
rides of a peak, and/or in the number of residues/oligosaccharide 
could account for the non-coincident peaks. 
There are several possible explanations for the changes observed. 
An increase in the carbohydrate/protein ratio, which leads to an 
increase in density, might be, for example, due to hydrolytic release 
of a carbohydrate-poor portion of ASGP-1. A decrease in the carbo-
hydrate/protein ratio would lead to a decrease in density, and could 
be due to hydrolytic release of carbohydrate rich portions of the 
glycoprotein. As will be indicated in Chapter III, lysosomes were 
not observed in the cells examined by electron microscopy. However, 
it is possible that extracellular hydrolases, secreted by other cells 
into the peritoneal cavity, could act on ASGP-1. The association of 
ASGP-1 to another glycoprotein (ASGP-2) at the cell surface (90) makes 
it accessible to the possible action of extracellular hydrolases. 
Increases in extracellular hydrolases, upon retinoid treatment, were 
reported previously (85 -87). Another factor that could cause changes 
in carbohydrate composition would be a change in the relative amount· 
or the type of sugars added to, or cleaved off· the glycoprotein at 
the posttranslational level. Several studies have demonstrated the 
involvement of retinoids in the glycosylation of glycoproteins. Some 
of these studies have been reviewed in the introduction of this 
chapter (76-82). Posttranscriptional or posttranslational modifica-
tions of the protein portion could also be modulated by retinoids, 
resulting in a larger or smaller polypeptide. Either the portion of 
the respective RNA transcript translated (through differential 
splicing or alteration of readthrough of termination codons)., or the 
posttranslational processing of the polypeptide could be affected. 
Several investigators have attempted to relate vitamin A status to 
RNA metabolism. For example, Tsai and Chytil (91) demonstrated a 
decreased elongation rate of RNA synthesis, and a decrease in the 
number of nacent RNA chains in the nuclei of liver cells isolated 
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from vitamin A-deficient animals. Studies by Reese et al. (92) 
suggested that retinoic acid treatment of rat prostate cells resulted 
in the induction of alkaline phosphatase activity. Another study by 
Russell et al. (93) indicated that the antiproliferative effects of 
retinoids on Chinese hamster ovary cells were related to the retinoids' 
ability to inhibit the G1-specific expression of ornithine decarboxy-
lase in those cells. The authors suggested that the inhibition might 
be due to posttranslational modification of the enzyme by trans-
glutamase (TGase), which would lead to loss of decarboxylase activity. 
They also suggested that the modified protein might be the one that 
acts as an initiation factor for ribosomal RNA synthesis (94). 
With respect to the studies presented in this chapter, some of 
the effects on ASGP-1 could be explained by one or a combination of 
the previously mentioned possible mechanisms.· For example, ASGP-1 
from group III MAT-C3 cells was as dense, but lower in molecular 
weight than control MAT-C3 ASGP-1. In addition, that glycoprotein 
was richer in the lower molecular weight oligosaccharides than control 
MAT-C3 ASGP-1. This effect could be due to hydrolytic release of both 
protein and carbohydrate portions of the glycoprotein, in such a 
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manner that the carbohydrate/protein ratio, and thus the density of the 
glycoprotein would not be changed. In the case of the MAT-CH ASGP-1 
from group III, there was a decrease in the density and an increase in 
the molecular weight of the glycoprotein as compared to control MAT-CH 
ASGP-1. The oligosaccharide patterns from the two glycoproteins coin-
cided. The lower density of group III MAT-CH ASGP-1 indicates a lower 
carbohydrate/protein ratio. Since the molecular weight was higher 
than that of control, it seemed possible that the hydrolytic posttrans-
lational modification of the protein portion of the glycoprotein was 
depressed, leading to a larger protein moiety and a lower carbohy-
drate/protein ratio. Alternatively, the increased density and 
molecular weight of MAT-BR group I ASGP-1, as compared to MAT-BR 
control ASGP-1, suggested a greater extent of glycosylation of the 
MAT-BR group I glycoprotein. 
This study and several others demonstrate the involvement of 
retinoids in glycoprotein production and modification. It appeared 
that retinoids affect both the protein and the carbohydrate moieties 
of glycoproteins. 
CHAPTER III 
EFFECT OF VITAMIN A ON THE MORPHOLOGY AND 
XENOTRANSPLANTABILITY OF THE 13762 RAT 
MAMMARY ADENOCARCINOMA SUBLINES 
Introduction 
Studies have shown that vitamin A and its analogs can modulate 
the differentiation patterns of several cell types in vitro and in 
vivo. Several of these studies were reviewed in Chapters I and II. 
Differentiation itself is defined by several biochemical as well as 
morphological parameters that may or may not be affected by retinoids. 
In an attempt to have a better understanding of the diverse effects 
of "vitamin A" status on different systems, investigations were 
directed to the cellular and subcellular level. In fact, several of 
the different effects of vitamin A on cells have been confirmed by 
studying the direct action of vitamin A on isolated cell organelles. 
It has been shown that vitamin A alters cell surface charac-
teristics in a variety of cell lines. Vitamin A restored contact 
inhibition of growth in both Balb/c 3Tl2-3 mouse fibroblasts (95) 
and L cells (96). In another study, Patt et al. (97) reported that 
the removal of retinal from the growth medium of 3T3 fibroblast cells 
slightly increased their saturation density, and that its addition 
reduced it in a dose dependent manner. In a contradictory report 
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(98), neither the 3T3 nor the L929 fibroblastic cells showed a 
significant change in growth rate or saturation density upon treat-
ment with free or RBP-bound1 retinol. 
Studies on cell adhesiveness indicated that retinol and retinoic 
acid increased the adhesion of Balb/c 3T12-3 transformed mouse 
fibroblasts to the substratum (99). In another study using Ag8-1 
Syrian hamster kidney fibroblasts (100), retinoic acid caused an 
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increase in cell-substratum adhesiveness and a. decrease in cell-to-cell 
cohesiveness. Hassell et al. (75) showed that chondrogenesis was 
inhibited by vitamin A. During this process, the cell shape was 
affected and the cellular accumulation of fibronectin was altered. 
Ogiso et al. (101) observed that retinoic acid treatment of a pluri-
potent teratocarcinoma cell line resulted in a decrease in the F9 
antigens, an enhanced secretion of plasminogen activator and the 
disappearance of peanut agglutinin receptors. Studies by Lotan 
(102) on the susceptibility of different human melanoma and breast 
carcinoma cell lines to retinoic acid growth inhibition indicated 
that the SK-BR-3 and 734B carcinoma cell lines were inhibited by 83 
and 50%, respectively. Both cell types spread and assumed a flattened 
morphology after 72 hr exposu;e to retinoic acid. Studies on the 
erythrocyte membrane indicated that the addition of vitamin A to 
erythrocytes in vitro induced cytoplasmic vacuolation followed by 
hemolysis (103). Distortion of red blood cell membrane by vitamin A 
was evidenced by the presence of cup shaped cells or those with 
dimpling of the cell membrane after 1 min exposure to 20 µg of vitamin 
1 · 1 b. d. i-Retino in ing prote n. 
A/ml of red cell suspension (104). Distention of the endoplasmic 
reticulum, the formation of lysosomes and the swelling of mitochon-
drial and Golgi apparatus vesicles were observed after the addition 
of vitamin A to fibroblasts in vitro (105). Matter and Bollag (106) 
observed a marked regression of mouse skin papillomas upon a single 
injection of the aromatic retinoid Ro 10-9359. Electron microscopic 
studies indicated that the drug caused an increase in the production 
of mucopolysaccharides and their secretion into the extracellular 
space. Vacuolization and loss of cytoplasmic constituents into the 
extracellular space following labilization of the plasma membrane 
were also observed. In addition, there was an increase in formation 
of lysosomes and necrotic cells. In another study on the keratoan-
thoma, topical applications of retinoic acid caused an increase in 
the number of Golgi cisternae and vesicles, and in the rough ento-
plasmic reticulum. This was accompanied by the formation of gap 
junctions (107). Brown et al. (108) studied the effect of vitamin 
A on the morphology of differentiating keratinocytes in vitro. High 
retinoid concentration in the medium resulted in the loss of the 
ability to stratify and keratinize. The cells were "oddly shaped", 
contained many vacuoles and developed elongated microvilli. Vitamin 
A also caused mitochondrial swelling (109), and labilization of 
lysosomal membranes (110, 111). 
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In several of the previously reviewed studies, it was suggested 
that retinoids exert most of their effects on cellular morphology via 
their actions on the different cellular membranes. It has been shown 
that once incorporated into membranes, retinal can be readily removed 
with chloroform/methanol, but is difficult to extract with hexane 
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(112). This observation and others on the effects of retinoids on 
membranes suggest a retinoid-lipoprotein interaction. However, there 
were studies on protein-free lipid monolayers (113, 114) and bilayers 
(115-118) which demonstrated that retinoids affect several physical 
parameters of the lipid bilayer component of membranes. All the 
previously reviewed studies, and others, demonstrate the potential 
of retinoids in affecting cellular growth and differentiation in 
several systems. Retinoids exert their actions on these processes 
via their effects, at the subcellular level, on the different 
cellular membranes and orga~elles. Based on the results of these 
many investigations, the effects of vitamin A on the morphology, 
growth and xenotransplantability of the 13762 rat mammary adenocar-
cinema sublines were studied. The results are presented in this 
chapter. 
Materials and Methods 
The animals, diets, experimental design and cell isolation 
procedures were as described in Chapter II. The samples examined 
from each dietary group consisted of a collection of cells from all 
the different rats of that group. 
Scanning Electron Microscopy (SEM) 
7 . 
Cells (2-5 x 10 /ml saline (0.9% w/v NaCl))were washed once to 
three times with saline and centrifuged at 100 x g. They were added 
to ~10 volumes of 1% glutaraldehyde in 0.1 M cacodylate, 0.1 M sucrose 
buffer, pH 7.4, and fixed overnight at 4°c. In the case of the MAT-Bl 
and MAT-C3 sublines, the cells (while still in fixative) were applied 
87 
to serum coated coverslips prepared by incubating sterile coverslips 
in 10% calf serum McCoys medium for 24 hrs. The cells were allowed 
to settle on the coverslips overnight at 4°C. In the case of the 
MAT-BR and MAT-CH sublines, the cells were washed three times in 
buffer, applied to polylysine-coated coverslips and allowed to settle 
for 15 min. The samples (after three washings in buffer in the case 
of MAT-Bl and MAT-C3 cells) were then treated with 1% osmium tetroxide 
in 0.1 M cacodylate, 0.1 M sucrose buffer for 30 min. They were 
washed one to three times in buffer and then dehydrated with a graded 
series (50%-100%) of aqueous ethanol solutions. The samples were 
dried at critical point using liquid co2. The coverslips were 
mounted on aluminum stubs and coated with 150 R (MAT-Bl and MAT-C3) 
to 200 i (MAT-BR and MAT-CH) of gold palladium. Samples were viewed 
with a Jeol JSM-35 scanning electron microscope operated at 15 kv. 
Micrographs were recorded on Polaroid film, type 55. 
Transmission Electron Microscopy (TEM) 
7 . 
Cells (2-5 x 10 /ml saline) were washed one to three times with 
saline and centrifuged at 100 x g. They were added to ~10 volumes of 
1% glutaraldehyde in 0.1 M cacodylate, 0.1 M sucrose buffer, pH 7.4, 
and fixed overnight at 4°c. The samples were washed three times in 
buffer and fixed secondarily with 2% osmium te·troxide in buffer for 
two hours. The cells were washed thoroughly in H2o (MAT-Bl and 
MAT-C3) or in buffer (MAT-BR and MAT-CH). In the case of the MAT-Bl 
and NAT-C3 sublines, the samples were stained in 1% aqueous uranyl 
acetate overnight at room temperature, and then washed once in water. 
(Note: The MAT-BR and MAT-CH samples were not stained at this stage.) 
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The samples were dehydrated with a graded series (50-100%) of ethanol 
and then washed three times in propylene oxide. The samples were 
infiltrated with a 1:1 propylene oxide and polybed and were capped 
either overnight (MAT-Bl and MAT-C3) or for 48 hrs (MAT-BR and f!,IAT-CH). 
The samples were then left uncapped for 7 hrs under vacuum. The cells 
0 were then imbedded in 100% polybed and cured at 60 C for 48 hrs. 
Silver sections were obtained using a diamond knife. Staining of the 
sections was performed using uranyl/acetate and lead citrate. Sections 
were viewed in a Philips EM 200 electron microscope. 
Parameters Studied by SEM and TEM 
Scanning electron microscopy was used to characterize the surface 
morphologies of the 13762 rat mammary adenocarcinoma. Besides the 
general morphology, two main parameters were evaluated: (1) number 
and degree of branching of the microvilli and (2) the frequency of 
contact between the tumor cells to form clusters of two or more cells 
(Figure 25). Both the number of branched microvilli per cell, and 
the number of branches/microvillus contribute .to the degree of 
branching and were not separated in this study. The observed mar-
phologies were categorized as previously defined (47, 54) where 
possible. The rest were termed "uncategorized". 
Transmission electron microscopy was used· to study the fine 
structure of the cells: (1) Cell viability was determined following 
the general fine structures of the cytoplasm and nucleus. Necrotic 
cells were defined by their disintegrating cytoplasm and their nuclei 
Figure 25. Scanning Electron Micrograph Illustrating a Cluster of 
Cells. MAT-C3 cells from a rat fed the purified diet 
supplemented with 12 mg retinoic acid/kg diet (MAT-C3 





. h . d h . 2 wit marg1nate c romatin; (2) the shape of the cell was also 
determined, e.g. spherical, oval, irregular, etc.; (3) the frequency 
and type of contact between cells. In microvillar contact (Figure 
26A), microvilli from one cell touched the microvilli or bodies of 
other cells. In cytoplasmic contact cytoplasm from different cells 
was continuous forming cytoplasmic bridges (Figure 27). If the 
cells were involved in both types of contact, they were categorized 
under 'cytoplasmic contact'. (4) Nucleoli were characterized by 
their position within the nucleus (119) (Figure 28). A nucleolus 
was considered marginated when it was located against the inner 
membrane of the nuclear envelope (Figure 28B). It was considered 
non-marginated when it was located towards the central region of 
the nucleus away from the nuclear envelope (Figure 28A). The number 
of nucleoli per cell was also noted. Nucleolar margination and the 
increase in the number of nucleoli per cell were associated with 
increased protein synthesis, as reviewed by Ghadially (119). Cells were 
categorized according to number 'of nuclei per cell and the position 
of the nucleolus within the nucleus. (5) Mitochondrial configuration 
was determined according to Ghadially (119). Normal looking mito-
chondria were referred to as showing an orthodox configuration 'high 
energy form' (Figure 29A), and mitochondria with dense matrix and 
swollen cristae as showing the condensed configuration, 'low energy 
form' (Figure 29B). Cells were categorized into those having mito-
chondria in the orthodox configuration, mitochondria in the condensed 
2A condensation of chromatin occurs along or adjacent to the 
inner nuclear membrane, while chromatin disappears from other parts 
of the nucleus (119). 
Figure 26. Transmission Electron Micrographs of MAT-BH Cells 
Illustrating the Criteria Used for Evaluating Contact. 
A. MAT-BH cells from a rat fed.the purified diet 
supplemented with 4.5 mg retinyl palmitate/kg 
diet (MAT-BH group I). Note microvillar contact 
between cells (arrows); the microvilli of a cell 
are touching the microvilli or the bodies of other 
cells. X 5000 
B. MAT-BH cells from a rat fed the purified diet 
supplem·ented with 120 mg retinoic acid/kg diet 
(MAT-BH group III). There is no contact between 





Figure 27, Transmission Electron Micrograph of MAT-CH Cells 
Illustrating the Criterion for Defining Cytoplasmic 
Contact. MAT-CH cells from a rat fed the purified diet 
supplemented with 120 mg retinoic acid/kg diet 
(MAT-CH group III). Note cytoplasmic bridges and 
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Figure 28. Transmission El~ctron Micrographs of 13762 Rat Mammary 
Adenocarcinoma Cells Illustrating the Criteria Used for 
Defining the Position of the Nucleolus Within the 
Nucleus. 
A. MAT-BR cell from a rat fed the purified diet 
supplemented with 120 mg retinoic acid/kg diet 
(MAT-BH group III). The cell has a non-marginated 
nucleolus (Nu) which is located towards the 
central region of the nucleus (N) away from the 
nuclear envelope. X 6500 
B. MAT-CH cell from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet 
(MAT-CH group II). The cell has a marginated 
nucleolus (Nu) which is located against the inner 
membrane of the nucleus (N). X 6500 
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Figure 29, Transmission Electron Micrographs of 13762 Rat Manunary 
Adenocarcinoma Cells Illustrating the- Criteria Used for 
Defining MitOchondrial Configurations. 
A. MAT-BR cell from a rat fed the purified diet 
supplemented with 120 mg retinoic acid/kg diet 
(MAT-BR group III). The mitochondria (M) are in 
the orthodox configuration, "high energy form". 
X 8000 
B. MAT-CH cell from a control rat fed the non-purified 
diet. The mitochondria (M) of this cell are in the 
condensed configuration, "low energy form". Note 
markedly ballooned mitochondrial cristae an~ dense 
mitochondrial matrix. X 8000 
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configuration, or a mixture of both. 
(6) Glycogen appeared as lucent or faintly stained areas 
(glycogen lakes) (119) within the cytoplasm. The glycogen content 
was estimated and cells were categorized into four different cate-
gories: "O", no glycogen; 11+11 , small amount of glycogen; "++", 
moderate amount of glycogen; "+t+", large amount of glycogen (Figure 
30). (7) Lipid appeared as electron-lucent to moderately electron-
dense droplets (119). The small droplets were usually spherical in 
shape. Large droplets were usually distorted or irregular in shape 
(Figure 30A). Cells were categorized according to the number of 
lipid droplets per cell. 
Tumor Growth and Xenotransplantability 
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The effect of vitamin A on ascitic tumor growth and xenotrans-
plantability was investigated: (1) The incidence of the MAT-BR and 
MAT-CH tumor development in the rats of the different dietary groups 
were recorded (Table V). (2) Transplantation of 13762 ascites cells 
into C57BL/6j mice on different vitamin A diets was performed as shown 
in Tables VI and VII. 
The mice (weanling) were processed through routine quarantine 
procedures. In the first experiment, in which the effect of dietary 
retinoic acid on xenotransplantability was studied, the mice were fed 
the closed formula non-purified diet until they were required for the 
experiment. The experiment started by dividing the mice into 3 major 
dietary groups (Table VI): (1) A control group in which the mice were 
kept on the non-purified diet; (2) a group fed the vitamin A-deficient 
purified diet supplemented with 4.5 mg retinyl palmitate/kg diet; 
Figure 30. Transmission Electron Micrographs of 13762 Rat Mammary 
Adenocarcinoma Cells Illustrating the Criteria Used for 
Estimating the Glycogen Content, and for Defining Lipid. 
A. Two MAT-CH cells from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet 
(MAT-CH group II). The cell on the right has a 
"+" glycogen (G) content. The one on the left has 
a "+!-" glycogen content (G). L, lipid droplets. 
X 5000 
B. Two MAT-CH cells from a rat fed the purified diet 
supplemented with 120 mg retinoic acid/kg diet 
(MAT-CH group III). The cell on the right has no 
"O" glycogen. The cell on the left has a "-H+" 







EFFECT OF VITAMIN A ON TUMOR GROWTH 
Tumor Line Group No. of Rats % Incidence 1 
MAT-BR c 5 40 (2/5) 
I 6 50 (3/6) 
II 6 100 (6/6) 
III 6 100 (6/6) 
MAT-CH c 5 40 (2/5) 
I 4 100 (4/4) 
II 5 80 (4/5) 
III 5 100 (5/5) 
1Incidence: Number of animals with tumors/total number of 
animals. 
TABLE VI 


















4.5mg R.P1kg Diet 
4 120 mg RA7kg Diet 
Non-purified Diet 
4.5 mg RP/kg Diet 
120 mg RA/kg Diet 
Non-purified Diet 
4.5 mg RP/kg Diet 
120 mg RA/kg Diet 
1Mice died, spontaneously,. of tumor growth. 
~ice appeared very ill, and were killed. 
3Retinyl palmitate. 
4Retinoic acid. 






















































lAs judged by the physical symptoms of tumor growth as discussed in text. 
2 ,4,6Each value was obtained from the average of three determinations on three out of each 
group. 
3,5Each value is obtained from the average of two determinations on two out of five mice 
in each group. 
3The low value might be due to the low amount of serum obtained from one of the mice 
tested. 
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(3) a group fed the vitamin A-deficient purified diet supplemented 
with 120 mg retinoic acid/kg diet. The mice (~70 days old) were 
injected with 1 x 106 MAT-BH or MAT-CH tumor cells, or with 0.9% NaCl, 
at the beginning of the third week of the experimental period. Tumor 
growth was monitored for 11 weeks after tumor injection. 
In the second experiment, the effect of vitamin A deficiency on 
xenotransplantability was studied. The weanling mice were started on 
the non-supplemented vitamin A-deficient purified diet upon arrival. 
A respective control group was fed the non-purified diet. The groups 
were kept on their respective diets for 16 weeks, after which the 
mice were injected with MAT-BH or MAT-CH tumor cells, or with 0.9% 
NaCl. The mice were monitored periodically for 8 weeks. The mice 
were then killed and the serum retinal levels were determined for 
sample mice from each group, using the method of Bieri et al. (120). 
As shown in the Results section, mice fed the vitamin A-deficient 
diet appeared to have normal serum retinal levels. 
Statistical Analysis 
The Chi square test was used to detect significant effects of 
diet on the different parameters studied. Significance levels were 
denoted between parenthesis w-en a statistically significant effect 
was observed. 
Results 
Scanning Electron Microscopy 
The MAT-Bl Subline. The control MAT-Bl cells resembled the 
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typical MAT-Bl cells which have been maintained as a stable line over 
several years (47). They were spherical in shape and had unbranched 
microvilli. Some had more microvilli than others. Ruffles, ridges 
and blebs were often associated with the cell surface (Figure 31). 
There were few free cells, the majority being in clusters or aggre-
gates of two or more with a low to moderate amount of contact between 
cells. The characteristics of the MAT-Bl cells from group I and II 
did not differ much from those of control; however, there might have 
been an increase in the surface density of microvilli with increased 
retinoic acid concentration in the diet. 
The MAT-CJ Subline. The control MAT-CJ cells had a mixed 
morphology. Most of the cells resembled the MAT-C cells (47) and 
some resembled the MAT-MR2-S morphology (54) (Figure 32). The 
control MAT-C3 cells had numerous unbranched microvilli and exhibited 
occasional blebs. Cells with branched microvilli were not seen in 
the samples examined. Some of the cells were present in clusters of 
two or more while others were free of contact to other cells. There 
were usually quite a few contact points between one cell and another 
in a clump. The predominant morphology of the MAT-CJ cells from 
group I was similar to that shown by control MAT-CJ cells. However, 
some of the cells had some ridged microvilli and/or indentations on 
the cell surface (Figure 33A). Branched microvilli occurred very 
rarely. Both cell clumps and free cells were seen. The MAT-CJ cells 
derived from group II (60 mg RA/kg diet) appeared to be highly 
adhesive and clumped. While the control MAT-C3 cells appeared 
spherical, most of the MAT-CJ cells from group II were not. Some 
Figure 31. Scanning Electron Micrograph of MAT-Bl Cell from a Control 
Rat Fed the Non-purified Diet. Note that the microvilli 
are not branched and often curved. There are areas free 
of microvilli. X 11,000 
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Figure 32. Scanning Electron Micrographs Illustrating the Different 
Morphologies of MAT-C3 Cells from Control Rats Fed the 
Non-purified -Diet. 
A. A MAT-C3 cell resembling the MAT-C (45) morphology 
with numerous short, stubby and unbranched micro-
villi extending straight from the cell body. X 9000 
B. A MAT-C3 cell resembling the MAT-MR2-S morphology 
(54) with unbranched microvilli. X 8500 
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Figure 33. Scanning Electron Micrographs of MAT-C3 cells from 
Groups I and II. 
A. Scanning electron micrograph of MAT-C3 cell from a 
rat fed the purified diet supplemented with 12 mg 
retinoic acid/kg diet (MAT-C3 group I). Note the 
ridged microvilli (arrows) and the indentation of 
the cell surface. X 12,000 
B. Scanning electron micrograph of MAT-C3 cell from a 
rat fed the purified diet supplemented with 60 mg 
retinoic acid/kg diet (MAT-C3 group II). Note the 
increase in the number and length of microvilli, and 




of the cells had an oval or elongated shape while others had irregular 
surfaces (Figure 33B). Indentations of the cell surface were also 
observed. The microvilli were still unbranched but appeared longer 
than those observed in the case of control and group I MAT-C3 cells. 
Several long microvilli appeared to link the cells of a clump 
(Figure 34). 
The MAT-BR Subline. The MAT-BR subline appeared to be a hetero-
geneous population as examined by scanning electron microscopy and 
illustrated in Figures 35 and 36. The majority of the population from 
each of the diet groups was categorized into several previously 
described morphologies (47). Some cells had the MAT-Bl morphology 
(Figure 35B), while others looked like the MAT-B cells (Figure 35A). 
In addition, some had the MAT-Cl morphology with branched microvilli 
(Figure 36B) while another group resembled the MAT-C cells (Figure 
36A). The rest of the population was a mixture of morphologies that 
could not be categorized into any of the previously identified mor-
phologies. Besides the general morphology, two main par~meters, 
the frequency of contact between cells, and the degree of microvillar 
branching, were examined, as shown in Tables VIII and IX, respectively. 
There was a significant (P < • 05) effect of diet on the frequency of 
contact, the significant difference being between group I and the 
control (P < • 005). The fraction of cells in group I that were 
involved in contact (~98%) was larger than that of control (~80%). 
Of groups II and III, ~80% and ~85% of the cells were involved in 
contact, respectively, and were not significantly different from 
control. The number of cells with branched microvilli was also 
Figure 34. Scanning Electron Micrograph of MAT-C3 Cells from Group II. 
MAT-C3 cells from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet (MAT-C3 
group II). Note long tangled microvilli linking the 
cells in a cluster. X 11,500 
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Figure 35. Scanning Electron Micrographs Illustrating the Different 
Morphologies ·of the Heterogeneous MAT-BH Subline. 
A. MAT-BH cell from a control rat fed the non-purified 
diet. The morphology resembles that of the MAT-B 
cells (45). Note ruffled surface, occasional blebs 
(arrow) and unbranched microvilli. X 7500 
B. Scanning electron micrograph of a MAT-BH cell from 
a rat fed the purified diet supplemented with 4.5 mg 
retinyl palmitate/kg diet (MAT-BH group I). The 
morphology resembles that of MAT-Bl cells (45). 
Note long curved microvilli, some of which adhere 
closely to an irregular cell surface. X 7000 
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Figure 36. Scanning Electron Micrographs Illustrating the Different 
Morphologies of the Heterogeneous MAT-BR Subline. 
A. MAT-BR cell from a control rat fed the non-purified 
diet. The morphology resembles that of MAT-C cells 
(45). Note numerous short, stubby microvilli 
extending straight from the cell surface. X 6000 
B. MAT-BR cell from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet 
(MAT-BR group II). The morphology resembles that of 
MAT-Cl morphology (45). Note irregular surface, 
covered with microvilli, several of which are 
extensively branched (arrows). Microvilli appear 
clustered and branching is not obvious when viewed 
straight on. Branching is more readily observed at 
the periphery. X 6000 
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TABLE VIII 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON 
THE FREQUENCY OF CONTACT BETWEEN THE 13762 MAT-BR 
RAT ASCITES MAMMARY ADENOCARCINOMA CELLS AS 






1 No Contact 










1The cell was free of contact with other cells. 
2The cell had contact with at least one other cell. 
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TABLE IX 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
MICROVILLAR BRANCHING OF THE 13762 MAT-BH RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS AS EXAMINED BY 
SCANNING ELECTRON MICROSCOPY 
Degree of Microvillar Branching 1 
Diet 
02 +3 ++4 
No. of Cells 
c 266 24 18 
I 188 "9 1 
II 402 30 15 
III 342 23 14 
1 Both the nl.Uilber of branched microvilli per cell and the 
numbers of branches of each microvillus contribute to 
what was termed "Degree of branching". 
2No branched microvilli/cell. 
3 . . 
Moderate degree of branching/cell. 
4High degree of branching/cell. 
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significantly affected by diet, the difference being between group 
I and the control (P< .01). In group I, only 5% of the cells had 
branched microvilli as compared to ~14% for the control. There was 
no significant effect of diet on the degree of branching (+vs++). 
12] 
The MAT-CH Subline. The MAT-CH cell population from each of the 
diet groups was also heterogeneous (Figure 37). A minority ranging 
from ~5-12% had branched microvilli and resembled the MAT-Cl mor-
phology (Figure 37B). Part of the remaining majority of cells had 
the MAT-C morphology with short, straight unbranched microvilli 
(Figure 37A). However, a good portion of the cells in each group 
could not be categorized into any previously determined morphology. 
These cells had a lot of microvilli that did not seem branched, but 
were present in clusters distributed over the cell surface. There 
was a significant difference between group I and control in the 
fraction of cells having branched microvilli which was ~5% and ~12% 
for group I and control, respectively (Table X). Groups II and III 
did not differ significantly from control in that respect; however, 
each of these groups was significantly different from control with 
respect to the degree of branching (P< .025). The samples from 
retinoic acid supplemented rats had a larger proportion of cells 
with a high degree of branching, relative to the control (Table X). 
The majority of the MAT-CH cells from each of the diet groups were 
involved in cell to cell contacts. However, group II had a higher 
(P< .05) fraction of cells (90.4%) involved in contacts, as compared 
to control (84.9%) (Table.XI). 
Figure 37. Scanning Electron Micrographs Illustrating the Different 
Identified Morphologies of the Heterogeneous MAT-CH 
Subline. 
A. MAT-CH cell from a rat fed the purified diet 
supplemented with 4.5 mg retinyl palmitate/kg diet 
(MAT-CH group I). The morphology resembles that of 
MAT-C cells (45) with numerous short, stubby, 
unbranched microvilli. X 7500 
B. MAT-CH cell from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet 
(MAT-CH group II). The morphology resembles that 
of MAT-Cl cells (45). Note extensive branching of 
most microvilli (arrows). Branching is more readily 
observed at the periphery. When viewed straight on, 
microvilli appear clustered and branching is hard to 
observe. Also note cells in background with MAT-C 
morphology. X 5000 
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TABLE X 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
MICROVILLAR BRANCHING OF THE 13762 MAT-CH RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS AS EXAMINED BY 
SCAi.'lNING ELECTRON MICROSCOPY 
Degree of Microvillar Branching 1 
Diet 
02 +3 ++4 
No. of cells 
c 291 33 6 
I 247 8 5 
II 251 17 12 
III 301 16 12 
1 Both the number of branched microvilli per cell and the 
number of branches of each microvillus contribute to 
what is termed "Degree of branching". 
2No branched microvilli/cell. 
3Moderate degree of branching/cell. 
4High degree of branching/cell. 
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TABLE XI 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON 
THE FREQUENCY OF CONTACT BETWEEN THE 13 762 MAT-CH 
RAT ASCITES MAMMARY ADENOCARCINOMA CELLS AS 
EXAMINED BY SCANNING ELECTRON MICROSCOPY 
Diet No Contact l Contact 2 
No. of Cells 
c 53 299 
I 47 213 
II 28 265 
III 60 294 
1The cell wasfree of contacc with other cells. 
2The cell had contact with at least one other cell. 
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Transmission Electron Microscopy 
Sample cells from each of the different groups were analyzed for 
general morphology, frequency and type of contact between cells, 
glycogen and lipid content per cell, and the characteristics of the 
mitochondria and nucleoli, as described in the experimental proce-
dures. The criteria used were as defined in the materials and methods 
section and in Figures 26-30. 
The MAT-Bl Subline. The c1;mtrol MAT-Bl cells were either. spherical 
or irregular in shape with curved unbranched microvilli. Some cells 
· seemed to have more microvilli than others (Figure 38). A large 
fraction of the cells (64.3%) were involved in microvillar or cyto-
plasmic contact or both (Table XII). The glycogen content per cell 
ranged from no glycogen observed to large amounts of glycogen as 
illustrated in Table XIII. The lipid content per cell ranged from 
0-11 droplets (Table XIV). The mitochondrial populations of ~93% of 
the control MAT-Bl cells were in the orthodox configuration, 'high 
energy state'. Only ~7% of the control MAT-Bl cells had a mixture 
of orthodox and condensed 'low energy state' mitochondria (Table XV-). 
Nucleoli were observed in some cells and not others, and ~20% of the 
cells with nuclei had more than one nucleolus. Some of the nucleoli 
were marginated and some were not (Table XVI).· All the control MAT-Bl 
cells examined appeared to be normal cells with a normal chromatin 
pattern (Figure 38). Most of group I MAT-Bl cells and some of those 
of group II were irregular in shape, and appeared to have more micro-
villi than control cells. There was a significantly (P < • 01) higher 
frequency of contact between group I cells than between control cells 
Figure 38. Transmission Electron Micrograph of MAT-Bl Cells from 





THE EFFECT OF RETINOIC ACID ON THE FREQUENCY AND TYPE 
OF CONTACT BETWEEN THE 13762 MAT-Bl RAT ASCITES HAMMARY 
ADENOCARCINOMA CELLS AS EXAL'1INED BY TRANSMISSION 
ELECTRON MICROSCOPY 
Contact No Contact 
Diet 1 2 
Microvillar Cytoplasmic 
No. of Cells 
c 7 11 10 
I 21 9 2 
II 17 2 8 
1Microvilli of cells are touching the microvilli or 
the cell body of one or more other cells. 
2cell bodies are in contact, and cytoplasmic bridges 




THE EFFECT OF RETINOIC ACID ON THE GLYCOGEN CONTENT OF THE 







1No glycogen present. 







3 Moderate amount of glycogen. 









THE EFFECT OF RETINOIC ACID ON THE LIPID CONTENT 
OF THE 13762 MAT-Bl RAT ASCITES MAMMARY 
ADENOCARCINOMA CELLS 
No. of Lipid Droplets/Cell 
Diet 
0 s.s 6-11 
No. of Cells 
c 3 18 5 
I 5 14 8 
II 0 9 6 
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TABLE XV 
THE EFFECT OF RETINOIC ACID ON THE MITOCHONDRIAL CONFIGURATION 
OF THE 13762 MAT-Bl RAT ASCITES MAMMARY ADENOCARCINOMA CELLS 
Mitochondrial Configuration 
Diet 1 2 1 
Orthodox Condensed Mixed 
No. of Cells 
c 28 0 2 
I 27 0 1 
II 16 13 7 
1Mitochondria in the orthodox configuration 'high energy form'. 
2Mitochondria in the condensed configuration 'low energy form'. 
3Both type 1 and type 2 mitochondria are present. 
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TABLE XVI 
THE EFFECT OF RETINOIC ACID ON THE NUCLEOLI OF THE 13762 
MAT-Bl RAT ASCITES MAMMARY ADENOCARCINOMA CELLS 
No. of Nucleoli/Cell Positions in Nucleus 
Diet 
0 1 >11 Marginated2 Non-Marginated3 
Number of Cells 
c 7 8 2 7 5 
I 8 12 2 9 7 
II 5 7 2 8 4 
12 to 3 nucleoli per cell. 
2The nucleolus is located at the nuclear envelope. 
3The nucleolus is located towards the central region of the 
nucleus away from the nuclear envelope. 
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(Table XII). The frequency of occurrence of. cytoplasmic bridges, however, 
was significantly lower in groups I (P < .01) and II (P < .05) than that of 
the control (Table XII). Most of group I cells did not seem to have 
any apparent glycogen lakes and the rest of the cells had little to 
moderate amounts of glycogen. This observation was significantly 
different (P < • 005) from that for control in that respect (Table 
XIII). There was no significant difference between control MAT-Bl 
cells and MAT-Bl cells from group I with respect to lipid content, 
nucleolar characteristics or chromatin as shown in Tables XIV, XVI, 
and XVII, respectively. No comparisons between control and group 
II MAT-Bl cells with respect to the former three parameters were 
made due to reasons that will be discussed below. Concerning mito-
chondrial configuration, again as shown for control, almost all 
group I cells examined had mitochondria in the orthodox form. 
However, there was a significant increase (P < • 005) in the relative 
number of group II c~lls having mitochondria in the condensed (36%) 
or mixed (19%) forms (Table XV). In addition, there was a signifi-
cant difference (P < .005) between group II and control MAT-Bl cells 
with respect to the chromatin pattern. Of the cells that had a 
visible nucleus, 50% had marginated chromatin (Table XVII). In 
conclusion, as judged by mitochondrial configuration, chromatin 
pattern and the general state of the cells, control and group I 
cells examined were all normal. However, a significant increase 
(P< .005) in cell necrosis was noted for group II MAT-Bl cells 
(Table XVIII, Figure 39). This latter observation led to the 
inability to analyze glycogen and lipid content, and nuclear char-
acteristics for this group. 
TABLE XVII 
THE EFFECT OF RETINOIC ACID ON THE CHROMATIN 
PATTERN OF THE 13762 MAT-Bl RAT ASCITES 




Number of Cells 
c 20 0 
I 21 0 
II 13 13 
11 A condensation of chromatin occurs along or 
adjacent to the inner membrane of the nuclear 
envelope, while chromatin disappears from 
other parts of the nucleus' (119). 
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TABLE XVIII 
THE EFFECT OF RETINOIC ACID ON THE VIABILITY OF 
THE 13762 MAT-Bl RAT ASCITES MAMMARY 
ADENOCARCINOMA CELLS AS EXAMINED BY 
TRANSMISSION ELECTRON MICROSCOPY 
General Fine Structure 
Diet 
Normal Necrotic! 
Number of Cells 
c 28 0 
I 31 0 
II 18 18 
1The cells exhibited disintegrating cyto-
plasms, and necrotic nuclei with marginated 
chromatin patterns. 
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Figure 39. Transmission Electron Micrograph of MAT-Bl Cells from 
Group II. MAT-Bl cells from rats fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet (MAT-Bl 
group II). These cells are necrotic as indicated by the 
disintegrating cytoplasm, and nuclei with marginated 
chromatin patterns. The mitochondria of these cells are 
in the condensed configuration "low energy form". 
Compare to control cells with normal fine structure (ih 
Figure 38) .. M, mitochondria; N, nucleus. X 5000 
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The MAT-C3 Subline. The control MAT-C3 cells were mostly 
spherical with moderate quantities of short to medium straight 
unbranched microvilli (Figure 40). The majority of the cells (91%) 
were involved in microvillar and/or cytoplasmic contacts with other 
cells (Table XIX). The majority of the cells lacked glycogen 
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(Table XX) and the rest had little or negligible amounts. The lipid 
content ranged form 0-20 droplets per cell, as shown in Table XX!. 
The mitochondria were all in the orthodox form, Table XXII. The 
number of apparent nucleoli per cell ranged from 0-3 (Table XXIII), 
and 69% of them were marginated. All the cells with nuclei had 
normal chromatin patterns, and appeared to be normal looking cells 
(Figure 40). 
The MAT-C3 cells from group I were usually spherical with short 
to medium length microvilli. There was a significant decrease 
(P < • 005) in the fraction of cells involved in contacts (Table XIX), 
as compared to control MAT-C3 cells. In addition, there was a 
significant increase (P < • 01) in the number of cells exhibiting 
glycogen lakes (Table XX). MAT-C3 cells from group I looked normal 
and did not differ significantly from control MAT-C3 cells with 
respect to lipid content, and nucleolar, mitochondrial (Tables XXI-
XXIII) and chromatin characteristics. 
The MAT-C3 cells of group II had an apparent increase in shape 
irregularity (Figure 41) as compared to control (Figure 40). They . 
seemed to have an increased number of microvilli, some of which 
·seemed longer and more curved than seen in the case of control. 
There was a significant difference (P < • 005) between group II cells 
and control cells with respect to the presence or absence of glycogen 
Figure 40. Transmission Electron Micrograph of MAT-C3 Cells from 
Control Rats Fed the Non-purified Diet. L, lipid; 
M, mitochondrion; N, nucleus; Nu, nucleolus. X 9000 
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TABLE XIX 
THE EFFECT OF RETINOIC ACID ON THE FREQUENCY AND TYPE OF CONTACT 
BETWEEN THE 13762 MAT-C3 RAT ASCITES MAMMARY ADENOCARCINOMA 
CELLS AS EXAMINED BY TRANSMISSION ELECTRON MICROSCOPY 





No. of Cells 
c 18 12 3 
I 9 .3 9 
II 19 10 0 
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1Microvilli of cells are touching the microvilli or the cell body 
of one or more other cells. 
2cell bodies are in contact, and cytoplasmic bridges are formed. 
Type 1 contact can sometimes be seen in this category. 
TABLE XX 
THE EFFECT OF RETINOIC ACID ON THE GLYCOGEN CONTENT OF 




01 +2 ++3 +++4 
No. of Cells 
c Tl 3 0 0 
I 13 8 0 0 
II 11 10 5 3 
1No glycogen present. 
2 Small amount of glycogen. 
3 Moderate amount of glycogen. 
4 Large amount of glycogen. 
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TABLE XXI 
THE EFFECT OF RETINOIC ACID ON THE LIPID CONTENT OF THE 
13762 MAT-C3 RAT ASCITES ~fr1ARY 
ADENOCARCINOMA CELLS 
No. of Lipid Droplets/Cell 
Diet 
0 .::5 6-10 11-20 >20 
No. of Cells 
c 3 14 11 6 0 
I 0 6 9 7 1 
II 0 9 9 5 4 
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TABLE XXII 
THE EFFECT OF RETINOIC ACID ON THE MITOCHONDRIAL CONFIGURATION 
OF THE 13762 MAT-C3 RAT ASCITES MAMMARY ADENOCARCINOMA CELLS 
Mitochondrial Configuration 
Diet 1 2 Mixed3 Orthodox Condensed 
No. of Cells 
c 39 0 0 
I 20 0 1 
II 29 0 2 
1Mitochondria in the orthodox configuration 'high energy form'. 
2Mitochondria in the condensed configuration 'low energy form'. 







THE EFFECT OF RETINOIC ACID ON THE NUCLEOLI OF THE 13762 
MAT-C3 RAT ASCITES MAMMARY ADENOCARCINOMA CELLS 
No. of Nucleoli/Cell Positions in Nucleus 
0 1 >11 Marginated2 Non-Marginated3 
Number of Cells 
8 14 7 20 9 
7 6 3 11 2 
3 11 7 17, 8 
1 2 to 3 nucleoli per cell. 
2The nucleolus is located at the nuclear envelope. 
3The nucleolus is located towards the central region of the 
nucleus away from the nuclear envelope. 
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Figure 41. Transmission E],ectron Micrograph of MAT:....c3 Cells from 
Group II. MAT-C3 cells from a rat fed the purified diet 
supplemented with 60 mg retinoic acid/kg diet (MAT-C3 
group II). Note the increased activity of the cells as 
indicated by the marked hypertrophy of the rough 
endoplasmic reticulum (RER) as compared to control cells 
in Figure 40. Dilatation and vesiculation of the rough 
endoplasmic reticulum is also observed. Also note the 
irregularity in shape as compared to control cell in 
Figure 40. L, lipid; M, mitochondrion; N, nucleus; 
Nu, nucleolus. X 5500 
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lakes, and an apparent difference in the amount of glycogen present, 
as shown in Table XX. MAT-C3 cells from group II did not differ 
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from control with respect to lipid content, or to the characteristics 
of the mitochondria, nucleoli (Tables XXI-XXIII) and chromatin. All 
the cells examined looked normal (Figure 41). However, it is 
important to mention that going from control to group I to group II, 
there was an apparently significant increase in the synthesizing 
activity of the MAT-C3, as evidenced by the hypertrophy of the rough 
endoplasmic reticulum and the active cytoplasm (Figure 41). 
The MAT-BR Subline. The control MAT-BR cells were usually semi-
spherical and sometimes irregular in shape. The microvilli were 
usually unbranched and moderate in number. Branched microvilli were 
sometimes seen on some of the cells. Almost all the cells were free 
of contact with others (Table XXIV). Almost half the number of cells 
examined (~44%) were devoid of glycogen (Table XXV). When present, 
glycogen lakes were usually low to moderate amounts. The lipid 
content varied between O and >20 droplets per cell (Table XXVI). 
A major fraction of the cells (~62%) had a mitochondrial population 
in the orthodox configuration. The rest of the cells had condensed 
mitochondria or a mixture of both mitochondrial configurations 
(Table XXVII). Most of the celLs (71%) had at least one nucleolus, 
and in 67% of the cases the nucleolus was marginated (Table XXVIII). 
Almost all the cells with nuclei (96%) had normal chromatin pattern 
and 97% of all cells had a normal general cytology. 
Group I MAT-BR cells (for example, the ones in Figure 26A) 
resembled control MAT-BR cells in the general morphology. A signifi-
TABLE XXIV 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
FREQUENCY AND TYPE OF CONTACT BETWEEN THE 13762 MAT-BH 
RAT ASCITES MAMMARY ADENOCARCINOMA CELLS AS EXAMINED 























1Microvilli of cells are touching the microvilli or the 
cell body of one or more other cells. 
2cell bodies are in contact, and cytoplasmic bridges are 




THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
GLYCOGEN CONTENT OF THE 13762 MAT-BH RAT ASCITES 








1 No glycogen present. 
2 Small amount of glycogen. 
3Moderate amount of glycogen. 
4Large amount of glycogen. 
+2 ++3 












THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON 
THE LIPID CONTENT OF THE 13762 MAT-BR RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS 
No. of Lipid Droplets/Cell 
Diet 
0 .ss 6-10 11-20 >20 
No. of Cells 
c 9 21 24 16 1 
I 1 21 29 12 4 
II 5 41 41 40 9 
III 0 38 30 27 6 
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TABLE XXVII 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
MITOCHONDRIAL CONFIGURATION OF THE 13762 MAT-BH RAT 
ASCITES M.A..'MHARY ADENOCARCINOMA CELLS 
Mitochondrial Configuration 
Diet 1 2 
Mixed3 Orthodox Condensed 
No. of Cells 
c 48 11 19 
I 36 1.1 9 
II 101 9 21 
III 73 8 18 
1Mitochondria in the orthodox configuration 'high energy 
fonn'. 
2Mitochondria in the condensed configuration 'low energy 
form'. 







TABLE XXVII I 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
NUCLEOLI OF THE 13762 MAT-BR RAT ASCITES MAMMARY 
ADENOCARCINOMA CELLS 
No. of Nucleoli/Cell Positions in Nucleus 
0 1 >11 Marginated2 Non-Marginated3 
Number of Cells 
15 30 6 28 14 
14 22 2 14 12 
34 42 17 54 22 
29 43 10 34 29 
1 2 to 3 nucleoli per cell. 
2The nucleolus is located at the nuclear envelope. 
3The nucleolus is located towards the central region of the 
nucleus away from the nuclear envelope. 
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cantly larger (P < .005) fraction of cells (28%) were involved in some 
type of contact with other cells, as compared to 3% for control (Table 
XXIV) • A significantly higher (P < • 05) incidence of cytoplasmic 
bridges was noted, as compared to control (Table XXIV). Group I 
cells were not significantly different from control with respect to 
glycogen content (Table XXV), mitochondrial configuration (Table 
XXVII) or the nucleolar characteristics (Table XXVIII). However, a 
significant increase (P < • 025) in the number of cells containing 
lipid was noted, as compared to controls (Table XXVI). Most of the 
cells with apparent nuclei had normal chromatin (92%) and 95% of 
all the cells looked normal. 
The MAT-BH cells from group II resembled those from control 
except that in some cases the microvilli seemed more curved and 
increased in number. There was a significant increase (P < .005) in 
the relative number of cells (~60%) involved in cell to cell contact, 
as compared to control (Table XXIV). In addition, the incidence of 
cytoplasmic bridges was significantly higher (P < • 005) than that for 
. ' 
control (Table XXIV). A significant increase (P < .025) in the fraction 
of cells with lipid (Table XXVI), and decrease (P< .025) in the 
fraction of cells with at least some condensed mitochondria (Table 
XXVII) was noted, as compared with control. Group II MAT-BH cells 
did not differ from control with respect to glycogen content (Table 
XXV) or the characteristics of the nucleoli (Table XXVIII). All the 
cells with apparent nuclei had normal chromatin patterns and all the 
cells examined appeared to be normal. 
The MAT-BH cells from group III (for example, the cells in 
Figure 26B) resembled control MAT-BH in the general morphology. 
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There was a significant increase (P < .005), with respect to control, 
in the relative number of cells involved in intercellular contact and 
those containing lipid (Tables XXIV and XXVI). MAT-BR cells from 
group III did not differ from control cells with respect to glycogen 
content (Table XXV), distribution of mitochondrial configurations 
(Table XXVII), or the characteristics of the nucleoli (Table XXVIII). 
Almost all the cells had a normal appearance, and the ones with 
visible nuclei had normal chromatin patterns. 
The MAT-CH Subline. Most of the control MAT-CH cells were 
usually spherical in shape with straight, short to medium microvilli, 
mostly unbranched. A good fraction of the cells (40%) were involved 
in intercellular contacts (Table XXIX). The glycogen and lipid 
contents are illustrated in Tables XXX and XXXI, respectively. As 
shown in Table XXXII, 39% of the cells contain mitochondria in the 
condensed configuration. Nucleoli were apparent in 71% of the cells 
examined (Table XXXIiI) and the majority of them were marginated. 
The chromatin patterns and the general cell cytology appeared to be 
normal for those cells. 
The MAT-CH cells from groups I, II and III resembled control 
cells in general appearance and microvillar characteristics. There 
were no significant differences between cells from these groups and 
those from control with respect to incidence and type of inter-
cellular contact (Table XXIX), lipid and glycogen content (Tables 
XXX and XXXI) or the characteristics of the nucleoli (Table XXXIII). 
Cells from each of group I, II and III differed significantly (P < • 005) 
from control with respect to mitochondrial configuration. As shown 
TABLE XXIX 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
FREQUENCY AND TYPE OF CONTACT BETWEEN THE 13762 MAT-CH 
RAT ASCITES MA..~Y ADENOCARCINOMA CELLS AS EXAMINED 
BY TRANSMISSION ELECTRON MICROSCOPY 
Contact No Contact 
Diet 1 Microvillar Cytoplasmi/ 
No. of Cells 
c 8 4 18 
I 12 11 51 
II 22 15 35 
III 30 25 50 
1Microvilli of cells are touching the microvilli or the 
cell body of one or more other cells. 
2 Cell bodies are in contact, and cytoplasmic bridges are 




THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
GLYCOGEN CONTENT OF THE 13762 MAT-CH RAT ASCITES 





c 11 7 
I 41 19 
II 27 25 
III 49 30 
1 No glycogen present. 
2small amount of glycogen. 
3 Moderate amount of glycogen. 










THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON 
THE LIPID CONTENT OF THE 13762 MAT-CH RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS 
No. of Lipid Droplets/Cell 
Diet 
0 .::S.5 6-10 11-20 >20 
No. of Cells 
c 0 7 5 12 5 
I 2 13 28 33 3 
II 1 12 16 34 12 
III 0 19 29 46 9 
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TABLE XXXII 
THE EFFECT OF RETINYL PALMITATE AND RETINOIC ACID ON THE 
MITOCHONDRIAL CONFIGURATION OF THE 13762 MAT-CH RAT 
ASCITES MAMMARY ADENOCARCINOMA CELLS 
Mitochondrial Configuration 
Diet 1 2 Mixed3 Orthodox Condensed 
No. of Cells 
c 19 8 4 
I 73 1 5 
II 65 4 4 
III 109 0 0 
1Mitochondria in the orthodox configuration 'high energy 
form'. 
~itochondria in the condensed configuration 'low energy 
form'. 








THE EFFECT OF RETINYL PALMITATE A.~D RETINOIC ACID ON THE 
NUCLEOLI OF THE 13762 MAT-CH RAT ASCITES MAMMARY 
ADENOCARCINOMA CELLS 
No. of Nucleoli/Cell Position in Nucleus 
0 1 >11 . i Marginate Non-marginated3 
Number of Cells 
6 13 2 15 2 
19 33 6 38 7 
18 33 6 39 6 
30 40 9 43 15 
1 2 to 3 nucleoli per cell. 
2 The nucleolus is located at the nuclear envelope. 
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3The nucleolus is located towards the central region of the nucleus 
away from the nuclear envelope. 
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in Table XXXII, most of the cells from each of these groups had mito-
chondria exclusively in the orthodox 'high energy form' configuration, 
as compared to only ~61% of the control MAT-CH cells. The chromatin 
patterns and general cell cytology appeared to be normal in all cases. 
Effects on Tumor Growth 
The incidences of ascites tumor development in the different 
dietary groups were compared. As shown in Table V, 100% incidence 
of MAT-BR ascites tumor line occurred in the all-trans-retinoic acid 
treated animals, while animals injected with MAT-BR tumor cells and 
fed the non-purified diet or the retinyl palmitate supplemented diet 
had 40% and 50% incidence, respectively. Thus, it appeared that 
excess doses of all-trans-retinoic acid did not decrease, but on the 
contrary, increased the incidence of the MAT-BH tumors in the rats. 
The effects of retinyl palmitate and retinoic acid on the MAT-CH tumor 
growth were also studied. As shown in Table V, control rats fed the 
non-purified diet had a 40% incidence of the MAT-CH ascites line. An 
increase to 80-100% tumor incidence occurred in the animals fed the 
retinyl palmitate or the all-trans-retinoic acid diets. Data on 
incidence of tumor growth in the case of MAT-Bl and MAT-C3 sublines 
were not obtained. 
Xenotransplantability 
Xenotransplantability of the different sublines of the 13762 rat 
mammary adenocarcinoma was studied previously (47, 54). In the case 
of the xenotransplantable sublines, the tumor-bearing mice increased 
in weight, and had very swollen abdomens and arched spines. Eventually, 
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the mice died. In the case of the non-xenotransplantable sublines, 
the tumor cells grew in the peritoneal cavities of the injected mice. 
The mice also manifested the external symptoms of tumor growth, as 
in the case of the xenotransplantable sublines. However, by the end 
of the 30 or 90 day observation period, the mice recovered. As shown 
in Table VI, there was no drastic effect of diet on the survival of 
mice fed the retinoic acid supplemented diet and injected with the 
MAT-BR and MAT-CH sublines, as compared to controls. Data on the 
external manifestations of tumor growth were not obtained. 
In the second. experiment, mice were fed the vitamin A-deficient 
purified diet for 16 weeks, as described under materials and methods. 
However, the average serum retinal levels of these mice did not differ 
significantly from those of control mice (Table VII). The mice were 
monitored periodically from the time of tumor injection until the 
time of killing, and external signs of tumor growth were noted. 
Based on the number of animals manifesting tumor growth symptoms, 
and on the number of mice that died of the tumors, it appeared that 
the incidence of the MAT-BR tumor in mice fed the vitamin A-deficient 
diet (9/13 mice with tumors) did not differ from that of the contro·l 
mice (3/5 mice with tumors). However, the fraction of animals that 
were fed the vitamin A-deficient diet and that died of the tumor 
(3/13) was lower than that for controls (3/5) .· Thus, feeding the 
vitamin A-deficient diet enhanced the survival of the animals (Table 
VII). In the case of the MAT-CH subline, all mice survived until the 
end of the experimental period. However, the mice on the vitamin A-
deficient diet had a higher incidence of tumor (9/12 mice) than that 




The objectives of the work presented in this chapter were to 
study the effects of dietary retinoic acid on the incidence, xeno-
transplantability, morphology and viability of the 13762 mammary 
adenocarcinoma sublines. The effects of retinoic acid on the homogen-
eous tumor cell populations,MAT-Bl and MAT-CJ, were more conclusive 
than those on the heterogeneous populations, MAT-BR and MAT-CH. High 
concentrations of retinoic acid in the diet (60 mg/kg diet) enhanced 
mecrosis in the MAT-Bl subline. This was judged by the disintegrating 
cytoplasms and necrotic nuclei of a good portion of the MAT-Bl cells 
examined. Cell rtecrosis was accompanied•by a significant increase 
in the condensed mitochondrial population. Cellular necrosis upon 
retinoid treatment was demonstrated previously in studies where 
retinol and retinyt .acetate (121) or the aromatic retinoid Ro-9359 
(106) were shown to have inhibitory effects on the incidence and 
development of skin papillomas. In the first study, retinoid treat-
ment caused an increase in lysosomal enzyme activities of the pre-
malignant cells, which lead to cellular necrosis (121). In the second 
study, retinoid treated skin papillomas had an increased number of 
lysosomes, as compared with normal epithelium; In the retinoid treated 
cells, labilization of the plasma membrane was accompanied by vacuoli-
zation and loss of cytoplasmic constituents and finally necrosis (106). 
In our studies, cellular lysosomes were rarely seen. However, 
an increase in the secretion of extracellular hydrolases was demon-
strated previously in other systems (85-87). Thus, it was possible 
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that hydrolases secreted, by other cells, into the peritoneal cavity 
could labilize the plasma membrane and/or the cellular organelles of 
the tumor cells to cause necrosis. Another possibility is that 
retinoic acid, through its surfactant and 'membrane seeking' activities 
(113-118) might labilize the plasma membrane leading to ingress of 
extracellular fluids, leakage of cytoplasmic constituents and finally 
necrosis, without the need for hydrolases. A third possibility is 
that retinoic acid, through adjuvant activities, might enhance the 
contribution of the host immune response to tumor regression. Reti-
noids stimulated both humeral and cell mediated immune responses in 
different systems (38-43). Some studies indicated that enhancement 
of antibody formation, to bovine serum albumin and to sheep red blood 
cells in mice, by retinal, required thymus-dependent lumphocytes, 
bone marrow-derived lymphocytes, and macrophages (41, 122). In other 
systems, antibody production could be stimulated by retinoid, not 
requiring the production of lymphocytes or macrophages (123). Vitamin 
A alone, or in combination with other treatments, was shown to stimu-
late the host anti-tumor immune response in several systems (19, 124, 
125). Cell-mediated immune response to the tumor could be achieved by 
activation of macrophages and/or cytotoxic T-cells, which recognize 
and lyse the tumor cells (126-128). In the case of the MAT-Bl cells 
used in this study, there is a possibility that high doses of retinoic 
acid in the diet could have enhanced the activation of macrophages 
and/or lymphocytes which could gain access to the peritoneal cavity 
and lyse the MAT-Bl cells. Killing of tumor cells can also be 
achieved by a combination of the action of hydrolases and the innnune 
response. 
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The effect of retinoic acid on the MAT-C3, MAT-BR and MAT-CH 
sublines were different from those on the MAT-Bl cells. The vitamin 
did not seem to affect the viability of these cells, as viewed by 
electron microscopy. In fact, 60 mg of retinoic acid/kg diet seemed 
to activate the MAT-C3 cells, as evidenced by the increased activity 
of the endoplasmic reticulum, and the cytoplasm in general. In 
contrast to the studies illustrating the anti-carcinogenic and anti-
tumor activities of retinoids, there are others demonstrating that 
the induction of malignant growth at some sites, such as the colon 
(129), mammary gland (130), and bladder (131) was not affected by 
retinoids. Interestingly enough, retinoids were shown to even 
enhance the induction or the growth of some tumors such as estrogen 
or progesterone induced mammary tumors in mice (132), or I1NU induced 
tracheal cancer in hamsters (133). In both cases, retinoid was 
administered in the diet. The increased synthetic activity in the 
MAT-C3 cells could be due to direct effects of retinoic acid on the 
amount of mRNAs transcribed and/or translated. Another possibility 
is that retinoic acid could affect glycoproteins which in turn could 
affect cellular functions by epigenetic mechanisms. These possi-
bilities were discussed in more detail in Chapter II. The observation 
that MAT-C3 cells became irregular in shape upon retinoic acid admin-
istration could be explained by the surfactant action of retinoids, 
discussed previously. Similar shape changes have been observed in 
other systems (104, 108). 
Several cell organelles were examined: Nuclei, nucleoli, chro-
matin, mitochondria, and endoplasmic reticulum. In addition to cell 
viability, other parameters such as glycogen and lipid content, 
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microvillar characteristics and cell-to-cell cohesiveness were also 
studied. Morphological studies indicated that in most of the cases 
where cell-to-cell cohesiveness was significantly affected, retinoid 
treatment enhanced cell-to-cell contact (MAT-Bl group I, MAT-BR group 
I, II and III, and MAT-CH group II). 
The effects on contact could be due to modulation, by the 
retinoids, of cellular properties which are involved in cell-to-cell 
recognition and cohesiveness. Among these properties are the pro-
duction of f.ibronectin and/or its receptors, and the cell surface 
glycoconjugates. The effects of retinoids on these parameters were 
demonstrated in the previously reviewed studies. For example, 
morphological and biochemical studies on rat islets revealed that 
13-cis-retinoic acid increased islet cell-to-cell cohesiveness, and 
at high concentrations, caused clumping of the cells (134). Cells 
in a clump were intact and gap junction linked the cells. These 
effects were accompanied by an increase in insulin release. 
In the present studies~ retinyl palmitate (MAT-CH group I) or 
retinoic acid (MAT-BH group II, and MAT-CH groups I, II and III) irt the 
diet appeared to reduce the occurrence of mitochondria in the con-
densed configuration 'low energy form'. This suggests enhanced 
respiratory activities of the cells, which require coupled mitochon-
dria in the orthodox configuration 'high energy form'. In the case 
of the MAT-Bl group II cells, there was an increase in the mitochon-
drial population having the condensed configuration, especially in 
the necrotic cell population. The effects of retinoids on mitochon-
drial morphologies and configurations were demonstrated previously 
(105, 109). For example, uncoupling and swelling of mitochondria 
• 
was observed upon addition of excess retinol to normal mitochondria 
(105, 109, 135). These observations were associated with increases 
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in permeability to the dye Nitroblue Tetrazolium (136) and to malate 
dehydrogenase and S-glucoronidase (137). Addition of retinol restored 
normal shape and function in abnormally shaped mitochondria isolated 
from hypovitaminosis A rats (138). Mitochondria isolated from livers 
of either hyper- or hypovitaminosis A rats displayed diminished P/0 
ratios and enhanced respiration (139, 140). It was suggested that 
retinol may function by stabilizing membranes and maintaining proper 
control of respiration and oxidative phosphorylation (141). Retinoic 
acid was shown to promote some mitochondrial swelling, but could not 
restore normal function to vitamin A poisoned rat mitochondria (135). 
However, Stillwell et al. (142) studied the effect of retinol and 
retinoic acid on the P/0 ratios of coupled mitochondria. Both 
retinoids were shown to uncouple mitochondrial oxidative phosphory-
lation. The fact that the effects observed were not site specific 
suggested that vitamin A acts as a general membrane bilayer disrupting 
agent (113-118). 
It was shown (14,3, 144) that electron transport is required for 
the condensed-to-orthodox ultrastructural transformation. This trans-
formation occurs in mitochondria under state IV conditions where 
exogeneous substrate is present and ADP is def'icient. The reverse 
transformation, from orthodox to condensed configuration,was shown 
to parallel suppression of acceptor control and oxidative phosphory-
lation. 
Nucleolar characteristics were examined, since an increase in 
the number of nucleoli per cell, and their margination were associated 
with increased protein synthetic activities (119). In our experi-
ments, there was no significant effect of retinyl palmitate or 
retinoic acid on these parameters. 
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The lipid content of the tumor cells was evaluated. In some of 
the cases, retinyl palmitate (MAT-BR group I) or retinoic acid (MAT-
BH groups II and III) caused an increase in the lipid content of the 
cells. In each of these cases, this observation was correlated with 
increased cell-to-cell cohesiveness. Lipid droplets represent a 
potential source of energy and provide short carbon chains which can 
be used in the synthesis of cellular,membranes and other cellular 
lipid containing material (119). While the presence of a few lipid 
droplets in the cytoplasm is considered normal, gross lipid deposition 
in some cells is considered pathological, and constitutes fatty 
degeneration, as reviewed by Ghadially (119). 
The glycogen content of tumor cells was also studied. In all 
cases studied, there.was no significant effect of retinyl palmitate 
or retinoic acid on the amount of glycogen present. However, when 
the mere presence or absence of glycogen was studied, it was shown 
that retinoic acid enhanced the appearance of glycogen in some cases 
(MAT-C3 groups I and II) and depressed it in others (MAT-Bl group I). 
Cells store glycogen as a metabolic fuel, and thus it might be assumed 
that its abundance is an indicator of increased cellular metabolic 
activity. This assumption, however, was proven to be wrong. In many 
instances, as reviewed by Ghadially (119), increased glycogen deposits 
in the cytoplasm indicated diminished usage rather than increased 
metabolic activity. 
Studies on the incidence and xenotransplantability of the ascites 
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sublines of the tumor indicated that in some cases (MAT-BR group II 
and III in rats, MAT-CH groups I, II and III in rats, MAT-CH in mice 
fed deficient diet) tumor incidence increased as compared to controls. 
In other cases (MAT-BR in mice fed the vitamin A-deficient diet) the 
tumor incidence was not affected, but the potential of the tumor to 
kill the animals was inhibited, as judged by observations on the 
survival of the tumor-bearing animals. My interest in the xenotrans-
plantability was based on the evidence for effects of retinoids on 
the innnune responses, as discussed previously (38-43). 
The observation that, in some of the cases of this study, tumor 
incidence was enhanced upon retinoid treatment is supported by similar 
observations in other systems, as reviewed previously in this chapter 
(132, 133). In another recent study on the relation of serum vitamin 
A and E and carotenoids on the risk of cancer in humans (145), it was 
found that the subjects with subsequent lung cancer had a higher mean 
base-line retinal leyel than that in their matched controls. Narisawa 
et al. (146) showed that animals with adequate intake of vitamin A 
develop significantly more tumors than animals deprived of vitamin A. 
It is possible that some tumors are retinoid dependent. 
CHAPTER IV 
SUMMARY 
The objective of this study was to determine the effect of 
dietary vitamin A on the 13762 rat mammary adenocarcinoma ascites 
sublines: MAT~Bl, MAT-C3, and two heterogeneous cell lines, MAT-BR 
and MAT-CH. Parameters measured were: 1) Tumor growth incidence; 
2) cell morphology; 3) the density, molecular weight and oligo-
saccharide pattern of the major membrane glycoprotein (ASGP-1); 
4) xenotransplaritability. 
Rats were fed either a non-purified, closed formula, vitamin 
A..:.adequate diet (controls), a vitamin A-deficient purified diet 
supplemented with 4.5 mg all-trans-retinyl palmitate/kg diet (2.4 
mg retinal equivalent/kg diet), or a vitamin A-deficient diet 
supplemented with 12, 60, 90~ or 120 mg all-trans-retinoic acid/kg 
diet. In the xenotransplantability studies, mice were fed either 
a non-purified, closed formula, vitamin A-adequate diet (controls), 
a vitamin A-deficient purified diet, or a vitamin A-deficient purified 
diet supplemented with 120 mg all-trans-retinoic acid/kg diet. 
Tumor passage was achieved by intraperitoneal injection of the animals 
with 1-3 x 106 tumor cells. 
The effects of retinoic acid and retinyl palmitate on the differ-
ent cell parameters of the four sublines are summarized in Tables 
XXXIV, XXXV, XXXVI and XXXVII. 
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TABLE XXXIV 
EFFECT OF DIETARY ALL-TRANS-RETINOIC ACID (RA) ON THE MORPHOLOGY, 
AND MAJOR MEMBRANE GLYCOPROTEIN (ASGP-1) OF THE 13762 MAT-Bl 




I II III IV 
174 
Retinoid and Supplement 12 mg RA/ 
kg diet 
60 mg RA/ 
kg diet 
90 mg RA/ 
kg diet 
120 mg RA/ 
kg diet 
ASGP-1 
Density NE + NE NE 
Molecular weight NE NE t NE 
Oligosaccharide pattern 
Peak II NE NE NE 
Peak III NE NE NE 
Peak IV NE NE NE 
Contact (TEM) 4 
General t NE 
Microvillar t NE 
Cytoplasmic + + 
Chromatin pattern NE tin 
(as compared to 100% margination 
normal in control) 
Nucleoli 
No./cell NE NE 
Margination NE NE 




No. of cells with glycogen + 
Amount of glycogen/cell NE 
Lipid 
No. of cells with lipid NE 
Amount of lipid/ cell NE 
TABLE XXXIV (Continued) 
3 Parameters 
Retinoid and Supplement 
Cell viability (as 



















120 mg RA/ 
kg diet 
.l 
Controls were fed a closed formula vitamin A-adequate, non-purified 
diet. 
2NE, no effect; t, increase; +, decrease; not examined. 
3 Parameters were previously defined in Chapters II and III. 
4As examined by Transmission Electron Microscopy. 
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TABLE XXXV 
EFFECT OF DIETARY ALL-TRANS-RETINOIC ACID (RA) ON THE MORPHOLOGY, 
AND MAJOR MEMBRANE GLYCOPROTEIN (ASGP-1) OF THE 13762 MAT-CJ 
RAT ASCITES MAMMARY ADENOCARCINOMA CELLS AS COMPARED 
3 Parameter 










(as compared to 100% 






No. of cells with glycogen 
Amount of glycogen/cell 
Lipid 
No. of cells with lipid 
Amount of lipid/cell 
TO CONTROL 1 , 2 
I 














60 mg RA/ 

















+ low MW 
oligosaccharides 
+ MW 
shoulder to the 
right of peak III 
3 Parameter 
Retinoid and Supplement 
Cell viability (as 
compared to 100% 
in control) 
Cell shape 
TABLE XXXV (Continued) 
I 



















Controls fed a closed formula vitamin A-adequate non-purified diet. 
2NE, no effect; t, increase; +, decrease; -, not studied. 
3 Parameters are as defined in Chapters II and III. 
4Molecular weight as indicated by elution volume from Bio-Gel P-4. 
5As studied by Transmission Electron Microscopy. 
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TABLE XXXVI 
EFFECTS OF DIETARY ALL-TRANS-RETINOIC ACID (RA) AND ALL-TRANS-RETINYL 
PAIMITATE (RP) ON THE INCIDENCE, MORPHOLOGY AND MAJOR MEMBRANE 
GLYCOPROTEIN (ASGP-1) OF THE 13762 MAT-BR RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS AS 
COMPARED TO CONTROLl,2 
3 Parameter 













Branching of Microvilli 
No. of cells with branched 
microvilli 
Degree of branching 
Chromatin pattern 
(as compared to 100% 






4.5 mg RP/ 
kg diet 
t 
NE or t 













60 mg RA/ 
kg diet 






















100% Normal 100% Normal 
NE NE 
NE NE 
,} occurrence NE 
of condensed 
configuration 
TABLE XXXVI (Continued) 
3 
Parameter 
Retinoid and Supplement 
Glycogen 
No. of cells with glycogen 
Amount of glycogen/cell 
Lipid 
No. of cells with lipids 
Amount of lipid/cell 
Cell Viability (as compared 
to 97% in controls) 
Cell Shape 
Incidence of tumor in rats 
(as compared to 40% in 
controls) 
I 
































Controls were fed a closed formula vitamin A-adequate, non-purified 
diet. 
2 NE, no effect; t, increase; +, decrease; , not examined; if con-
tradictory effects were recorded, they represent different cell combi-
nations (replicates). 
3Parameters were previously defined in Chapters II and III. 
4 Average molecular weight as indicated by elution volume from Bio-Gel P-4. 
5As examined by Scanning Electron Microscopy. 
6As examined by Transmission Electron Microscopy. 
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TABLE XXXVII 
EFFECTS OF DIETARY ALL-TRANS-RETINOIC ACID (RA) AND ALL-TRANS-RETINYL 
PALMITATE (RP) ON THE INCIDENCE, MORPHOLOGY AND MAJOR MEMBRANE 
GLYCOPROTEIN (ASGP-1) OF THE 13762 MAT-CH RAT ASCITES 
MAMMARY ADENOCARCINOMA CELLS AS 
COMPARED TO CONTROLl,2 
3 Parameter 










Branching of Microvilli 
No. of cells with 
Branched Microvilli 
Degree of Branching 
Chromatin Pattern (As 







4.5 mg RP/ 
kg diet 

















60 mg RA/ 
kg diet 































TABLE XXXVII (Continued) 
3 Parameter 
Retinoid and Supplement 
Glycogen 
No. of cells with glycogen 
Amount of glycogen/ cell 
Lipid 
No. of cells with lipids 
Amount of lipid/cell 
Cell Viability (as compared 
to 100% in control) 
Cell Shape 
Incidence of tumor in rats 
(as compared to 40% in 
control) 
I 































1 Controls were fed a closed formula vitamin A-adequate, non-purified 
diet. 
2NE, no effect; t, increase;· +, decrease; , not examined; if con-
tradictory effects were recorded, they represent different cell combina-
tion (replicates). 
3Parameters were previously defined in Chapters II and III. 
4 Average molecular weight as indicated by eluti9n volume on Bio-Gel P-4. 
5As examined by Scanning Electron Microscopy. 
6As examined by Transmission Electron Microscopy. 
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A 100% growth incidence of MAT-BR ascites tumor line in rats 
occurred in the groups supplemented with either 60 or 120 mg retinoic 
acid/kg diet. Groups fed the control diet or the retinyl palmitate 
supplemented diet had 40% and 50% incidence of MAT-BH ascitic growth, 
respectively. Control rats had a 40% incidence of ascitic MAT-CH 
growth. An increase to 80-100% MAT-CH ascitic growth incidence 
occurred in the animals fed the retinyl palmitate or the retinoic 
acid supplemented diets. 
The effects of dietary vitamin A on cell morphology were more 
conclusive for the homogeneous cell lines, MAT-Bl and MAT-C3, than 
for the heterogeneous cell lines MAT-BH and MAT-CH. The Chi square 
test was used to detect significant effects of diet on the different 
parameters studied. 
High retinoic acid concentrations in the diet (60 mg retinoic 
acid/kg diet) induced necrosis in the MAT-Bl subline, and enhanced 
the synthetic activity of the MAT-C3 line as indicated by hyper-
trophy of the rough endoplasmic reticulum and active cytoplasm. 
Both retinyl palmitate and retinoic acid, in the diet of MAT-BH tumor 
bearing rats, tended to enhance MAT-BH cell-to-cell cohesiveness and 
the occurrence of lipid deposits in the cell. In the MAT-CH subline, 
a decrease in the occurrence of mitochondria in the condensed config-
uration (low energy form) was observed upon dietary supplementation 
with retinyl palmitate or retinoic acid. 
Both retinoic acid and retinyl palmitate affected the density, 
molecular weight, and the oligosaccharide pattern of ASGP-1. The 
effects varied with the tumor subline, and with the type and concen-
tration of retinoid used. The vitamin A analogs appeared to affect 
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both the carbohydrate and protein moieties of the glycoprotein. The 
Wald-Wolfowitz two-sample runs test (147) was used to detect signifi-
cant changes (P < .05) in the molecular weight of ASGP-1. The test 
could not be applied to the density or oligosaccharide profiles, 
since the peaks consisted of fewer than 9 points each. 
The observation that, in some cases, replicate experiments on 
the MAT-BR and MAT-CH did not give consistent results might be due 
to the heterogeneity of these cell lines. 
Compared to controls (fed a closed formula non-purified vitamin 
A-adequate diet), there was no effect of diet on the survival of mice 
injected with MAT-BH or MAT-CH cells and fed a purified vitamin A-
deficient diet supplemented with 120 mg retinoic acid/kg diet. Mice 
fed a vitamin A-deficient diet for 16 weeks were not retinal-deficient. 
MAT-BH tumor incidence in these mice did not differ from that of 
control mice; however, there was an enhanced survival of the tumor 
bearing mice. In th~ case of MAT-CH subline, all of the mice survived. 
However, the mice fed the vitamin A-deficient diet had a higher inci-
dence of MAT-CH ascitic growth as compared to controls. 
Further study will be required to identify the structural changes 
in ASGP-1, to determine more specifically the mechanisms behind the 
changes observed, and to study in more detail the effect of excess 
retinoic acid on other parameters of the tumor· cells such as membrane 
fluidity and membrane enzyme content, cell surface receptor mobility, 
and agglutinability by concanavalin A. 
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